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Abstract
Mastitis is an economically distressing disease in the dairy industry. Bacterial
pathogens enter the gland and encounter cell types that release immune mediators
including interleukin (IL)-8. IL-8 has two membrane bound receptors: CXCR1 and
CXCR2. CXCR1 and CXCR2 are expressed on neutrophils and other cell types in other
species but their expression is unknown in the bovine mammary gland. To test this,
mammary tissue samples from six Holstein dairy cows were subject to dual
immunofluorescence with bovine specific CXCR1 and CXCR2 antibodies and cell type
markers. CXCR1 was expressed on alveolar epithelial cells, fibroblasts, and
leukocytes. CXCR2 expression was identified on alveolar epithelial cells and
leukocytes. Within the bovine CXCR1 sequence, key amino acids 122, 207, 245, 327,
and 332 have the potential to influence receptor efficiency in ligand binding and/or
downstream signaling effects. Previous studies have linked some of these SNPs with
mastitic phenotypes. The three SNPs (VWHRR, VWHKH, and AWQRR) were
representative of 99% of the population. To test the haplotype effect, forty Holstein
dairy cows were haplotyped and experimentally challenged with Streptococcus uberis.
Various infection responses were monitored until 28 days post challenge. All cows with
the VWHRR x VWHRR (n=5) and AWQRR x VWHRR (n=6) haplotype combinations
required antibiotic treatment to clear infection whereas only 33.33% of VWHRR x
VWHKH cows (n=7) required antibiotic therapy (p=0.0153). Cows with a VWHRR
homozygous haplotype displayed significantly higher milk (1.05 ± [plus or minus] 0.21)
and mammary (1.23 ± [plus or minus] 0.17) scores and AWQRR x VWHRR cows had
v

significantly lower milk (0.17 ± [plus or minus] 0.18) and mammary (0.41 ± [plus or
minus] 0.14) scores then cows of all other haplotype combinations (p=0.0263 and
p=0.0161 respectively) indicating levels of inflammation differed among haplotype
combinations. VWHRR homozygous cows also displayed significantly higher S. uberis
bacteria counts (981.99 ± [plus or minus] 1947.05) then cows of any other haplotype
combination (p=0.0348). Somatic cell counts (p=0.1399) and milk yield (p=0.6126)
were not influenced by haplotype. Coupling this knowledge together indicates the
critical role this receptor-ligand complex plays in a cow’s ability to resist mastitis.
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Chapter I: Introduction

1

Mastitis, an inflammation of the mammary gland, is an ongoing issue in the dairy
industry that costs producers billions of dollars annually (NMC 2005). Bacteria most
frequently cause mastitis. Once bacteria enter the gland, encountered cells generate
danger signals and release cytokines; among them interleukin-8 (IL-8), growth related
oncogene-γ (GRO-ɣ ), and epithelial cell neutrophil-activating peptide-78 (ENA-78).
Interleukin-8 is released by a variety of cell types in response to stressors such as:
reactive oxygen species (ROS), bacterial fragments, and other pro-inflammatory
cytokines (DeForge et al. 1993; Grob et al. 1990). Interleukin-8 is responsible for three
key immune related functions: stimulating the migration of other cell types (Grob et al.
1990; Takata et al. 2004), regulation of host cell survival (Kettritz et al. 1998;
Shamaladevi et al. 2009), and modulation of chemokine and cytokine profiles.
Moyes (2009) revealed S. uberis induced mastitis causes a 1054-fold increase in
IL-8 gene transcription. Experimental challenge with S. uberis, E. coli and Serratia
marcescens demonstrated increased concentrations of IL-8 in the milk in comparison to
uninfected glands (Bannerman et al. 2004; Riollet et al. 2000; Shuster et al. 1997).
Direct infusion of IL-8 into the mammary gland increased the number of leukocytes,
antibodies and serum albumin in the milk suggesting IL-8 impacts several immune
related functions in the gland (Watanabe et al. 2008).
Interleukin-8 has two specific, membrane-bound receptors, CXCR1 and CXCR2.
CXCR1 is expressed on neutrophils, other immune cells (Del Rio et al. 2001; Grob et al.
1990; Holmes et al. 1991; Lee et al. 1992; Moser et al. 1991), human mammary stem
cells, and breast cancer cells (Ben-Baruch 2003). CXCR2 is also expressed on
2

immune cells, especially neutrophils (Ahuja and Murphy 1996; Grob et al. 1990; Lee et
al. 1992; Moser et al. 1991; Sprenger et al. 1994) as well as endothelial cells, and some
epithelial cells (Wislez et al. 2006). In bovine mammary tissue, it is unknown which cell
populations express these two receptors. Because of the increased concentrations of
IL-8 observed in mastitic glands and IL-8’s association with immune related functions, a
more thorough understanding of the cell types expressing these receptors is critical for
understanding mammary gland responses to infection.
The bovine CXCR1 gene has several single nucleotide polymorphisms (SNPs)
that our lab has associated with mastitis (Youngerman et al. 2004). The key SNP
demonstrating this association was at position +735, but several others also were
identified (+365, +621, +980, +995) (Table 1). The +365 SNP, located on the first
extracellular loop, involves a T to C switch, a valine to alanine amino acid change, has
close proximity to the ligand binding site and the ability to affect ligand binding and
affinity (Leong et al. 1994; Monteclaro and Charo 1996; Pighetti et al. 2012). The +621
SNP induces an early stop codon truncating the receptor and removing its ability to
perform internal signaling upon ligand binding if it is expressed. The +735 SNP has
been linked to increased cases of subclinical mastitis (Youngerman et al. 2004),
decreased calcium signaling upon IL-8 binding (Rambeaud and Pighetti 2007),
decreased neutrophil migration to the site of infection (Rambeaud and Pighetti 2005),
decreased ROS generation from neutrophils to aid in bactericidal activities, and
increased neutrophil survival (Rambeaud et al. 2006). The +980 and +995 SNPs are
located towards the intracellular C-terminus of the receptor. Through specific
3

manipulation of the receptor sequence, the C-terminus including the +980 and +995
SNPs was identified as playing a key role in binding of intermediates, migration, and
receptor internalization and polymorphisms in the nucleotide sequence could impact
these functions (Raman et al. 2010). Based on the bovine CXCR1 SNPs, amino acid
haplotypes were developed and three (VWHKH, VWHRR, AWQRR) were
representative of more than 99% of the sample Holstein population (Pighetti et al.
2012). Cows with haplotypes that include fewer conserved amino acid changes may
demonstrate decreased receptor functionality, making VWHRR the haplotype most
likely to display the most decreased function. This suggests that examining CXCR1
haplotypes instead of the individual SNPs within the receptor’s gene may provide a
more comprehensive understanding of a cow’s potential for fighting off mastitis and
streamline efforts for genetic selection.
Based on IL-8 increases during multiple types of infection, known IL-8 receptors
expressed on multiple cell types in other species, and the genetic association of CXCR1
SNPs to disease susceptibility, I hypothesize that the IL-8 receptors, CXCR1 and
CXCR2, will be present on more than just immune cells within the mammary gland and
that cows with two copies of the specific CXCR1 haplotype, VWHRR, will display an
increased susceptibility to developing mastitis following direct challenge. The following
two objectives will allow for the testing of the preliminary hypothesis:
1. Evaluate types of cells expressing CXCR1 and CXCR2 in bovine mammary
tissues.
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2. Determine the association of CXCR1 haplotype on resistance to direct S. uberis
challenge.
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Table 1: CXCR1 SNP summary and location.

SNP
+365
+621
+735
+980
+995

Base Change
TA
GA
GC
AG
AG

Amino Acid Change
VA
WStop
QH
KR
HR

6

Location
1 intracellular loop
2nd extracellular loop
3rd intracellular loop
C-terminus
C-terminus
st
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Chapter II: Literature Review

10

Mammary Gland
The mammary gland is a complex and essential organ to bovines and other
mammals where it serves two main functions: to provide the offspring nutrition for
development/growth and immunity. Offspring consuming milk secreted form the
mammary gland are provided nutrition and immunity. The milk contains essential fatty
acids, amino acids, vitamin and minerals needed for calf growth and development
(Armstrong 1959). These nutrients are provided in a form that is highly digestible and
absorbable to the still developing offspring. Secreted milk also contains antimicrobial
factors, immunoglobulins, lysozyme, complement, lactoferrin, and leukocytes, which are
crucial components for the development of both gut and systemic immunity (Gopal and
Gill 2000; Larson et al. 1980; Oviedo-Boyso et al. 2007). These immune components
are essential for bovine offspring survival because, unlike humans, dams do not pass
antibodies to their offspring in utero (Larson et al. 1980). Furthermore, immune
components and cells present within the milk also aid the mammary gland itself in
fighting off invading pathogens (Bishop et al. 1976; Oviedo-Boyso et al. 2007; Reiter
1978; Reiter and Oram 1967).
The bovine udder is composed of four individual mammary glands separated by
a layer of connective tissue lamellae (Dyce and Wensing 1971). Within the parenchyma
of each gland exists the secretory units which are termed alveoli (Figure 1) (Dyce and
Wensing 1971). The alveoli differ in size depending on their location in the gland, but
are generally between 0.1 and 0.2 millimeters in diameter (Dyce and Wensing 1971).
The alveoli include a layer of milk secreting epithelial cells, which will secrete milk into
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the lumen of the alveoli (Figure 1). Connecting the alveoli are a series of small
excretory ducts (Dyce and Wensing 1971). As you descend further down the gland, the
ducts merge and increase in size until you reach lactiferous ducts (Dyce and Wensing
1971). The dozen or so lactiferous ducts then converge on the large cistern that
connects to the ductus papillaris, or streak canal where milk is secreted (Dyce and
Wensing 1971). The mammary gland’s ductal and alveolar structures develop in a pad
of adipose. Cellular signals that aid in mammary gland differentiation and development
are provided by the collective stromal tissue which includes the adipose pad (Neville et
al. 1998). By the time a cow reaches first parturition, the udder is fully developed with
the mammary epithelium supported in stroma containing adipose cells (Figure 2)
(Hovey et al. 1999; Neville et al. 1998). The stroma also contains other cell types
including fibroblasts and immune cells that can aid in development and differentiation
and supports vascularization which is a necessity for the mammary gland (Neville et al.
1998). The supply of blood to the udder comes from the mammary artery, which runs
from the pudendal trunk, along the abdomen and then to the udder. From there, the
blood flow continues in a series of smaller vessels to provide nutrients to the essential
milk producing cells. Endothelial cells construct the blood vessels within the gland, and
are present in high numbers because milk production requires a high level of
vascularization (Dyce and Wensing 1971). Innervation of the bovine mammary gland is
fairly uncomplicated. The iliohypogastric and ilioinguinal ventral branches innervate the
cranial glands and the skin of the udder whereas the caudal glands are innervated by
the mammary branches of the pudendal nerve. There is little innervation within the
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gland itself with only sympathetic innervation to blood vessels and the teat sphincter
(Peeters et al. 1949).
There are many cell types present within the mammary gland that reside within
several tissue types (Table 2, Table 3). Epithelial cells are the primary component of
the epithelium (epithelial cells, myoepithelial cells, and lumen) and comprise 70% of the
cells in the parenchyma (Akers et al. 2006; Capuco et al. 1997). Epithelial cells
synthesize and secrete milk (Bauman et al. 2006). Their main role is to remove
nutrients from the neighboring blood capillaries and use the obtained nutrients to
synthesize milk (Bauman et al. 2006). In order to facilitate these nutrient transfer roles,
epithelial cells are polarized, meaning the basal side has a much different role than the
apical side. The basal side, neighboring the basement membrane and capillaries,
retrieves nutrients and the apical side, neighboring the alveolar lumen, synthesizes and
secretes milk (Emerman and Pitelka 1977). The endoplasmic reticulum is linked to the
synthesis of milk proteins and the golgi apparatus to the production of lactose and the
secretion of milk components in secretory vesicles (Bauman et al. 2006). The number
of mitochondria present within a given epithelial cell is in direct correlation with the
energy needs of the cell during lactation (Veltri et al. 1990). Furthermore, because
epithelial cells line all the ductal and alveolar structures, they are often the first cell type
encountered by invading pathogens and as such help initiate the immune response (De
Schepper et al. 2008).
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Figure 1: Diagram of an alveolus in a lactating mammary gland with surrounding
myoepithelial cells and blood vessels. (Anderson et al. 1985)
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Figure 2: Developed murine mammary gland cross-section displaying epithelial cell (E)
lined lumens (L) containing milk (M) surrounded by supporting adipocytes (A) (Jensen
et al. 1991).
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Table 2: Tissue types and structures present in bovine lactating gland (Akers et al.
2006).

Tissue Type
Parenchyma
Lumen
Stroma

Percentage
30
55
15

Table 3: Approximate cell types present in bovine lactating mammary parenchyma with
ranges dependent upon gland region (Capuco et al. 1997).

Cell Type
Endothelial cells
Epithelial cells
Fibroblasts
Leukocytes
Myoepithelial cells

Percentage
6.3 – 6.4
70.7 – 69.7
12.6 – 14.3
4.5 – 5.4
5
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Figure 3: Cross-section of a fully developed mammary gland characterized by
completely developed alveoli with maximized lumen area and minimized stromal area
(Howe et al. 1975).
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Myoepithelial cells comprise about five percent of the (Table 2, Table 3)
mammary parenchyma (Akers et al. 2006; Capuco et al. 1997) and are seen in tandem
with epithelial cells where they lie between epithelial cells and the basement membrane.
They attach to both the basement membrane and epithelial cells by hemidesmosomes
and desmosomes, respectively (Glukhova et al. 1995). Myoepithelial cells are
associated with both alveolar and ductal epithelial cells. Those associated with alveoli
are discontinuous and form a basket-like network around the alveoli but still allow some
alveolar epithelial cells direct contact to the basement membrane. Those associated
with ductal epithelial cells form a continuous layer that runs parallel to the long axis of
the duct (Emerman and Vogl 1986; Gusterson et al. 1982). Myoepithelial cells are
responsible for the contraction of epithelial cells and the subsequent release of milk into
the lumen of the alveoli and ducts (Bissell et al. 2003). This action is completed by the
actin and myosin that fills the cytoplasm of myoepithelial cells and is induced by
oxytocin release associated with the initiation of milking stimulus (Gorewit et al. 1983;
Lefcourt and Akers 1983). Lastly, myoepithelial cells play a great role in the production
of basement membrane components that include fibronectin, collagen IV, bioactive
laminins, and nidogen (Gudjonsson et al. 2002; Gusterson et al. 1982; Warburton et al.
1982).
Fibroblasts are typically associated with the stroma portion of the parenchyma
(Table 2), comprise 12.6 – 14.3% (Table 3) of the mammary gland, and have been
linked to a variety of essential functions (Akers et al. 2006; Capuco et al. 1997). They
synthesize both collagen and extracellular matrix, which are major components of
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connective tissues (Grinnell 2003). They also play a critical role in wound healing.
Fibroblasts are recruited to wound sites by chemoattractant factors and are then
responsible for generating new extracellular matrix needed for cell ingrowth (Singer and
Clark 1999). Fibroblasts are intricately associated with the mammary stromal tissue
(Hovey et al. 1999). They are known to release one or more diffusible factors that
preferentially select for epithelial cell growth and differentiation as well as alveolar
morphogenesis in the mammary gland (Darcy et al. 2000).
In the mammary gland, there are also lymphatic ducts that connect lymph nodes
to the mammary gland and the blood supply. Lymphatic ducts carry a yellow liquid,
lymph, which drains into veins. Lymph is primarily comprised of waste being funneled
away from tissues and lymphocytes, a type of leukocyte (UK 2012). Leukocytes or
white blood cells are needed for defense of the mammary gland (Paape et al. 2002a).
Shafer-Weaver et al. (1996) observed several populations of leukocytes in a healthy
mammary gland (Table 4). Cells expressing CD2 account for the largest fraction (53%)
of leukocytes in the mammary gland. They include all cells in T-cell lineage and natural
killer cells. This fraction can be broken down further into T-helper cells that are CD4
positive, T-cytotoxic/suppressor cells that are CD8 positive, and γδ T-cells, each
represents approximately 13, 31, and 9% of the leukocytes in the gland respectively. Bcells, those responsible for specific antibody presentation and secretion, account for
35% of the leukocytes in the gland. Cells expressing CD5 include: some T-cells, some
B-cells, and T-cell precursors, thymocytes that together represent 41% of the
leukocytes present. Thus the majority of the leukocytes present in the mammary gland
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are lymphocytes. Another significant proportion (43%) of the leukocytes present are
antigen presenting cells (APC), which express major histocompatibility complex II (MHC
II). Antigen presenting cells consist of B-cells, macrophages and dendritic cells.
Macrophages and dendritic cells along with neutrophils, and some B-cells also express
CD11, and these cells comprise 18% of the leukocytes in the gland. Another marker,
CD172a is unique to monocytes and granulocytes (neutrophils, basophils, and
eosinophils), accounts for 25% of the leukocyte population, despite the attempted
exclusion of these cell types using a ficoll gradient. Lastly, non-T-cells, non-B-cells
were identified via WC2 expression and represented only 4% of leukocytes in the
mammary gland (Shafer-Weaver et al. 1996).
The Shafer-Weaver study specifically looked at mononuclear cell populations
and exempted granulocyte populations, making it necessary to evaluate the leukocyte
populations within the mammary gland further. Nickerson and Heald (1982) observed
leukocytes present within both healthy and S. aureus infected quarters including
populations of granulocytes (Table 5). They discovered that within the healthy
mammary quarter lymphocytes were the dominant population comprising 69.06% of the
leukocytes, which is congruent with the Shafter-Weaver et al. (1996). Antibody
secreting plasma cells made up the next largest fraction representing 13.58% of the
leukocytes. The last fraction is made up of mast cells, monocytes/macrophages, and
neutrophils and these are responsible for only 10.19%, 1.89% and 0.04% of the
leukocytes in the healthy quarter respectively. When a quarter is infected with S.
aureus, the percentages of cells shift from primarily lymphocytes with minimal
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granulocytes to approximately half lymphocytes and half granulocytes. Lymphocytes
and plasma cells still represent a large fraction at 40.5% and 17.38% respectively.
However, neutrophils increase dramatically to account for 32.9% of leukocytes in the
infected quarter. The percent of monocytes/macrophages also increases to 5.39%, but
the percent of mast cells decreases to 3.83%. These results indicate that when the
gland is healthy lymphocytes provide the primary defense mechanism, but under an
infection state, granulocytes, especially neutrophils, become primarily responsible for
gland defense (Nickerson and Heald 1982).
Bovine milk from a healthy gland, like the gland tissue itself, contains many
leukocyte populations (Table 5). The predominant population is T-cells (88%) which
includes CD4+ T-helper cells (20%), CD8+ T-cytotoxic/suppressor cells (50%), γδ Tcells (3%) and some natural killer cells. Unlike in the gland, B-cells do not comprise a
significant portion of milk leukocytes, accounting for only 6%. The remaining group are
CD45R cells, which represent some T and B-cells, macrophages, and neutrophils; and
is responsible for 17% of milk leukocytes (Taylor et al. 1994). The CD45R group does
not include all T-cells due to the fact that as T-cells mature and differentiate they shed
their CD45 receptors (Mackay et al. 1990).
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Table 4: Leukocyte populations present in a healthy, mid-lactation bovine mammary
parenchyma following the use of a ficoll gradient to exclude the majority of granulocytes
(Shafer-Weaver et al. 1996).

Leukocyte (Marker Used)
B-cells (surface IgM)
T-cells & NK cells (CD2)
T-helper cells (CD4)
B-cells, T-cells, & Thymocytes (CD5)
T-cytotoxic cells (CD8)
DC cells, Monocytes, Macrophages,
Neutrophils, and some B-cells (CD11)
Antigen-presenting cells (MHCII)
Monocyte/Granulocyte (CD172a)
γδ T-cells (WC1)
Non-T, B-cells (WC2)

Percent Cells Staining Positive
35
53
13
41
31
18
43
25
9
4
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Table 5: Leukocyte populations present in healthy and S. aureus infected mammary
quarters (Nickerson and Heald 1982).

Leukocyte
Lymphocytes
Plasma cells
Neutrophils
Monocytes/Macrophages
Mast cells

Percent Cells in Healthy
Quarter
69.06
13.58
0.04
1.89
10.19
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Percent Cells in S. aureus
Infected Quarter
40.50
17.38
32.90
5.39
3.83

Table 6: Leukocyte populations present in milk secretions from a healthy, lactating
bovine mammary gland (Taylor et al. 1994).

Leukocyte (Marker Used)
B-cells (WC3)
T-cells (CD2)
T-helper cells (CD4)
T-cytotoxic cells (CD8)
γδ T-cells (WC1)
Leukocytes (B-cells, subset of T-cells,
Macrophages, Neutrophils) (CD45R)

Percent Cells Staining Positive
6
88
20
50
3
17
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T-cells are the predominate leukocyte present in both healthy mammary
parenchymal tissue and milk (Shafer-Weaver et al. 1996; Taylor et al. 1994). T-cells
play a role in eliciting an immune response against invading pathogens and token
antigens (Kaufmann 1988). T-cells are subdivided into two categories, αβ T-cells and
γδ T-cells (Pardoll et al. 1987). Those of the αβ subtype can be further divided into Thelper (CD4+) cells and T-cytotoxic (CD8+) cells (Zlotnik et al. 1992). Both T-helper
cells and T-cytotoxic cells recognize token antigens in the context of MHC on APCs
using a T-cell receptor (TCR) that has α and β chains and can be present in a variety of
tissue types (Fowlkes and Pardoll 1989). Once a T-helper cell recognizes antigen it
releases a plethora of cytokines that aid activating cytotoxic T-cells, dendritic cells and
macrophages, as well as the maturation of B-cells into effector or plasma cells (Zlotnik
et al. 1992). Cytotoxic T-cells are responsible for destroying infected and/or damaged
cells. The infected and/or damaged cells are recognized by cytotoxic cell T-cell
receptor (TCR) interaction with antigen that is presented by MHC I (Park et al. 1993).
T-cells expressing the γδ TCR are typically less predominant than those expressing the
αβ TCR (Hein and Mackay 1991), and unlike αβ T-cells do not always require antigen
presentation via MHC II to recognize antigen (Mackay et al. 1988). The γδ T-cells are
typically involved in recognizing antigens of a lipid nature or bacterial danger signals
such as degrading cells (Mackay and Hein 1991).
B-cells are another cell type that is highly present within the mammary
parenchyma (Shafer-Weaver et al. 1996). The primary role of B-cells is to make
antibodies specific to one recognized antigen (Clark and Ledbetter 1994). B-cells can
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also serve to present antigens via MHC II (Cassell and Schwartz 1994). Naïve B-cells
circulate in healthy blood and tissue and once they are exposed to antigen, they
become one of two distinct subclasses: a plasma cell or a memory cell. Plasma cells
are responsible for the secretion of specific antibodies against a single antigen in order
to tag the invading pathogen and make it more recognizable for the immune system to
destroy, as well as prevent binding to host cells (Clark and Ledbetter 1994). Memory
cells also are specific to a single antigen and are formed from a single activated B-cell
during the initial infection. Memory cells live for long periods of time and allow for a
more rapid response to specific antigen upon sequential infection (Clark and Ledbetter
1994).
Monocytes are critical to mammary gland health but are present in low numbers
due to the fact that once they migrate into the tissue they differentiate into macrophages
or dendritic cells. They are however, always present in the blood supply and upon
activation are quickly recruited to the sites of infection. Monocytes migrate from the
blood supply into tissues via adhesions to endothelial cells lining blood vessels
neighboring infection sites. Selectins expressed on endothelial cells weakly bind
glycoproteins on activated monocytes and allow them to roll across the vessel wall and
slow enough to bind more strongly via surface integrins that have counter-receptors
expressed on endothelial cells. After this tight bond is established monocytes enter
tissue via extravasation (Imhof and Aurrand-Lions 2004). Once at the site of infection
they differentiate into macrophages and dendritic cells that can both engulf and destroy
pathogens via phagocytosis (Gordon and Taylor 2005). Monocytes also enter tissue in
26

the manner described above to replace resident macrophages as needed when there is
not an infection present (Gordon and Taylor 2005).
Macrophages are considered the ever-present sentinels of the mammary gland.
Their primary function is to maintain tissue homeostasis and defense through clearing
senescent cells, repairing damage (Gordon 1986; Gordon 1998), phagocytizing
pathogens, and subsequently killing pathogens to eliminate the threat they pose to the
gland (Outteridge and Lee 1981). Macrophages also take on the role of antigen
presenting, displaying antigens from phagocytized bacteria in conjunction with MHC II to
make them more readily recognized by T-helper cells (Politis et al. 1992). Several
studies have also demonstrated the importance of macrophages in perpetuating the
immune response by the release of chemoattractants (interleukin-1 (IL-1) and ENA-78)
that are important for neutrophil and T-cell responses (Allmann-Iselin et al. 1994;
Splitter and Everlith 1989; Ziegler et al. 1984).
Dendritic cells share several similarities with macrophages. They too can
phagocytize and kill invading pathogens as well as present antigens to T-helper cells via
MHC II (Banchereau and Steinman 1998). Dendritic cells also stimulate clonal
proliferation, differentiation into effector or memory cells, and the secretion of cytokines
upon T-helper cell binding to MHC II (Paape et al. 2002b). They are also known to
produce cytokines like tumor necrosis factor alpha (TNF-α) and interleukin-12 (IL-12) to
perpetuate the immune state, help recruit other immune cells such as neutrophils and
macrophages, and enhance the cytotoxic abilities of natural killer cells and T-cytotoxic
cells (Hope et al. 2003). Furthermore, dendritic cells play a crucial role in activating the
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adaptive immune response. Once matured, dendritic cells can present antigen directly
to T-helper cells which in turn interact with antigen primed B-cells to initiate the cascade
that develops memory plasma B-cells (Steinman and Hemmi 2006). Dendritic cells can
be found in alveolar structures, interalveolar spaces, and in the epithelium within the
bovine mammary gland (Maxymiv et al. 2012). However, they are distinct from
macrophage populations. Macrophages express MHC class II, CD11chi, and CD14hi
whereas dendritic cells show MHC class II, CD11chi, CD14lo, and CD205 marker
expression. These differences in receptor expression make the two cell populations
distinguishable via multicolor immunohistochemistry and flow cytometry assays
(Maxymiv et al. 2012).
Neutrophils are cells that are recruited into tissues by the presence of infection.
If no infection exists, their numbers will be relatively low, but if an infection is present,
their numbers will show a marked increase. Neutrophils are recruited to the site of
infection via chemoattractants and they enter tissues in much the same manner as
described for monocytes (Burg and Pillinger 2001). More precise information about
neutrophils is provided in the section titled ‘Immune Mediators’.
Mastitis
Mastitis or mammary gland inflammation, an ongoing issue in the dairy industry,
costs the dairy industry billions of dollars annually (NMC 2005). Losses come in a
variety of forms, some of which include: discarded milk from infected cows, antibiotic
therapies, replacement of culled cows, and extra labor costs for time spent treating and
caring for mastitic cows (Akers and Nickerson 2011; Fetrow 2000; Jones et al. 1994;
28

Short and Lawlor 1992). However, the greatest loss is attributed to decreased milk
production in cows that are subclinically and clinically infected (Akers and Nickerson
2011; Fetrow 2000; Jones et al. 1994; Short and Lawlor 1992). A number of factors can
influence the probability or susceptibility of a cow contracting mastitis and includes: age,
parity, stage of lactation, pathogen type, genetics, season, and climate (Hogan and
Smith 1987; Oliver and Mitchell 1983; Ruegg 2003; Smith et al. 1985). Instance of
mastitis increases with parity, the more offspring a cow has the more likely it becomes
that she will contract mastitis (Ruegg 2003). Cows not actively being milked or in early
lactation are more prone to developing mastitis. Cows in late stages of lactation have a
significantly decreased instance of mastitis (Oliver and Mitchell 1983). Furthermore,
warm temperatures and moist climates favor the growth of most pathogens, increasing
their total numbers and thus the probability they will come into contact with a cow and
cause mastitis (Hogan and Smith 1987). Because of the variety of factors, there is
diversity in the instances mastitis across herds and breeds of dairy cattle. Herds are
known to be have incidence of mastitis in 20-50% of their cows (Wilson et al. 1997) and
breeds that have been subjected to selection methods for increased milk yield like
Holstein dairy cows tend to be associated with increased mastitis (AIPL 2013).
Furthermore, mastitis continues to be one of the primary reasons for decreased
productive life (AIPL 2013).
Mastitis has two types of causes: non-infectious or infectious. Non-infectious
causes are incidents such as blunt trauma to the udder. These traumas arise from
kicks from another cow or collision with objects in the cows’ housing environment.
Infectious causes are much more diverse and caused by a microorganism entering the
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gland and establishing infection. Some infectious agents are: algae, yeasts, and
viruses, but the cases of mastitis that result from these infectious agents are a very
small fraction compared to those cases that arise from bacteria.
Bacteria are present everywhere in the cows’ environment. Making good
management practices absolutely crucial to the control and prevention of mastitis (Gill et
al. 1990; Jayarao and Wolfgang 2003; Ruegg 2003). During machine milking, bacteria
present on or within the milking unit can easily be transferred into the teat end due to
the relaxed state of the teat sphincter during the milking process (Hogan and Smith
1987). Bacteria can also be introduced during the administration of intramammary
infusions, such as those used during the dry off (non-lactating) period (Hogan and Smith
1987). Another common means of entrance is directly from the environment. Soil in
pastures, bedding, and pre/post milking sanitation processes all are possible sources of
infection (Bushnell 1984; Hogan et al. 1989; Pankey and Drechsler 1993). Once the
bacteria gain entrance to the mammary gland, they benefit in a variety of ways. The
gland itself is protection from other environmental factors that could be detrimental to
the bacteria. The gland is warm, providing the bacteria with a temperature closer to
their optimum growth and replication temperatures. The milk present within the gland
provides an energy source for bacterial growth. Thus, once bacteria are inside the
mammary gland, they are in an environment that allows them to not only survive but
potentially thrive.
Mastitis bacterial pathogens are highly prevalent and hundreds of causative
species have been isolated. Mastitis has two basic classifications: clinical and
subclinical. Clinical cases have symptoms such as inflammation (redness, heat,
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swelling, and pain), dramatically increased somatic cell counts (SCC), atypical or
decreased milk production, abnormal or lack of activity, fever and weight loss
(Youngerman et al. 2004a). Subclinical cases produce less severe symptoms where
visual changes in the udder are not observed, but somatic cell counts are still elevated,
just not to the degree of a clinical incidence (Youngerman et al. 2004a). Subclinically
infected cows cause the greatest loss of profit to farmers with a 10 to 12% decrease in
milk production associated with a single subclinically infected quarter over the length of
a single lactation (Akers and Nickerson 2011). The panel of symptoms observed with a
particular case of mastitis can often be tied to the type of pathogen. Incidences of E.
coli mastitis are typically of rapid onset with altered and decreased milk production and
in some cases fever and lethargy and will clear in a few days (Smith and Hogan 1993).
However, S. aureus mastitis typically start similarly to E. coli but lead to subclinical
cases that show some alteration and reduction in milk production and can persist for the
life of the cow (Sutra and Poutrel 1994).
These bacterial pathogens can be broken into two groups: environmental and
contagious (Smith 1983). Environmental pathogens include a larger array of bacteria
that are present everywhere in the surroundings of the dairy herd (Smith et al. 1985).
Herds that demonstrate a pattern of increased clinical mastitis instance, particularly in
spring and summer months when the weather is hot and wet, often indicate the
establishment of environmental pathogens present in the mammary gland (Smith et al.
1985). Common environmental pathogens include Streptococcus uberis, Streptococcus
agalactiae Streptococcus dysgalactiae, coliform bacteria (Escherichia coli, Klebsiella
spp.), coagulase-negative Staphylococci (CNS), and Enterobacter spp. (Hogan and
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Smith 1987; Jayarao and Wang 1999; Jayarao and Wolfgang 2003). Because of their
prevalence, they are often used as models to study mastitis.
Streptococcus uberis is an environmental pathogen causing approximately 1426% of all subclinical and clinical mastitis cases (Jayarao et al. 1999; Phuektes et al.
2001). It is the most commonly isolated pathogen during the dry period (Bramley 1984;
Bramley and Dodd 1984; Oliver 1988). In vitro studies have indicated that within two
hours after S. uberis exposure to epithelial cells, S. uberis closely associates with
epithelial cell microvilli (Matthews et al. 1994). Further observation revealed pedestal
formation indicating adherence of S. uberis with the epithelial cell membrane (Matthews
et al. 1994). This adherence occurs between S. uberis and epithelial cells as well as
extracellular matrix proteins (Almeida et al. 1996). Glycosaminoglycans facilitate
adhesion (Almeida et al. 1999). Glycosaminoglycans are covalently bound to the
abundant membrane proteins proteoglycans and often used by bacteria for attachment
(Liang et al. 1992). Fang et al. (1999) identified a molecule specific to S. uberis,
lactoferrin-binding molecule that aided in bacterial attachment. Lactoferrin, a milk
protein, when added to in vitro mammary epithelial cell cultures facilitated the binding of
S. uberis to epithelial cells (Fang and Oliver 1999). Mammary epithelial cells bind
lactoferrin (Rejman et al. 1994), that in turn facilitates internalization of S. uberis into
bound epithelial cells (Fang et al. 2000). This molecule was later re-named S. uberis
adhesion molecule (SUAM) and the development of SUAM specific antibodies that
decreased S. uberis adherence (Almeida et al. 2006). This evidence suggests that
SUAM may be a novel candidate in the development of alternative treatments or
preventative measures for S. uberis based mastitis.
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Inflammatory Cytokines Linked to Infection
The innate immune system gives the mammary gland the ability to combat a
variety of invading pathogens. Due to its relatively non-pathogen-specific methods of
pathogen recognition, the innate system provides a rapid response even upon first
exposure (Oviedo-Boyso et al. 2007). Initial recognition stems from pathogenassociated molecular patterns (PAMPs), which help to initiate the immune response.
Bacterial cells are distinct from mammalian cells allowing for specific immune
responses. Their cell walls are comprised of components like lipopolysaccharide (LPS),
peptidoglycan and lipoteichoic acid that are considered PAMPs (Bannerman et al.
2004b; Han et al. 2003). PAMPs are recognized by a class of membrane-bound
receptors termed toll-like receptors (TLRs) (Rosenberger and Finlay 2003). TLR4 binds
bacterial components such as LPS, polypeptides and host associated compounds such
as fibrinogen, heat-shock proteins, polypeptides that are released under stressful
conditions (Beutler 2004; Takeuchi et al. 2000). Another TLR, TLR2 recognizes grampositive associated molecules such as peptidoglycan and lipoteichoic acid (Takeuchi et
al. 2000). TLR5 detects flagella that are characteristic of many species of motile
bacteria and TLRs 3 and 9 bind dsRNA and dsDNA associated with endosomes
respectively (Rosenberger and Finlay 2003; Wagner 2004). In addition to TLRs,
chemical components of bacteria can be recognized by complement molecules,
formylated peptide receptors, mannose-binding lectins, and ficolins (Akira and Takeda
2004; Fournier and Philpott 2005; Rooijakkers et al. 2005; Rosenberger and Finlay
2003). Once bacteria are recognized by these avenues, they induce the production of
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immune mediators, especially cytokines, from local cell populations in the mammary
gland (Bannerman et al. 2004b).
Cytokines are considered key immune mediators and some are associated with
the inflammatory state, including TNF-α, IL-1, and interleukin-6 (IL-6). Bacteria enter
the mammary gland and can interact with both epithelial cells and macrophages. The
binding of bacterial PAMPs to TLRs induces production and secretion of TNF-α. TNF-α
stimulates the recruitment and bactericidal activities of neutrophils, in addition to
perpetuating the inflammatory state by aiding in the production of IL-1, IL-6, and
arachidonic acid metabolites (Atkinson et al. 1990). Following experimental challenge
with S. uberis, increases in milk TNF-α were observed approximately 72 h post infusion
(Bannerman et al. 2004a). Furthermore, Moyes et al. (2009) demonstrated that during
S. uberis mastitis, TNF-α transcripts were increased 45-fold, which most likely
contributes to increased levels of TNF-α protein. TNF-α is the first cytokine to increase
in milk following experimental challenge with E. coli and Serratia marcescens. Peak
TNF-α concentrations were reached between 12 and 18 post bacterial inoculation and
persisted for up to 48 h (Bannerman et al. 2004a; Bannerman et al. 2004b; Riollet et al.
2000; Shuster et al. 1997). Increased levels of TNF-α are also seen in sera and milk
after infection with other coliforms including: E. coli, Klebsiella oxytoca, Pseudomonas
aeruginosa, and Enterobacter spp. (Nakajima et al. 1997). LPS injection into the gland
has yielded conflicting results. After direct infusion of LPS into the gland, no significant
increases in TNF-α were witnessed (Shuster et al. 1993). Contrastingly, increased
TNF-α has been linked to endotoxic shock in acute cases of mastitis suggesting there
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may be an intermediate process that could tie TNF-α and mastitis together (Havell
1989; Persson Waller et al. 2003; Ślebodziński et al. 2002).
Interleukin-1, like TNF-α, can perpetuate the inflammatory state and stimulate
neutrophil migration and killing through stimulating the release of other mediators such
as IL-8 (Bannerman et al. 2004b; Boulanger et al. 2003; Stein et al. 2003). Production
of IL-1 is induced following recognition of bacterial presence by TLRs on macrophages
and epithelial cells (Oviedo-Boyso et al. 2007; Yamanaka et al. 2000; Zhang and
Issekutz 2002). IL-1 is known to be present in milk during the early stages of S. uberis,
E. coli, and S. aureus infections (Bannerman et al. 2004a; Bannerman et al. 2004b;
Oviedo-Boyso et al. 2007; Riollet et al. 2000; Yamanaka et al. 2000; Zhang and
Issekutz 2002). Increases in concentrations of IL-1 begin shortly after increases in
TNF-α (Riollet et al. 2000; Shuster et al. 1997). Following S. uberis mastitis, there is a
14-fold increase in IL-1 transcripts, which could contribute to increased levels of IL-1
protein (Moyes et al. 2009). LPS injection into the mammary gland produced increased
IL-1 concentrations more rapidly, displaying increased levels of IL-1 as early as 2.5-4 h
post injection (Shuster et al. 1993). Increased levels of IL-1 were not observed in milk
following challenge with Serratia marcescens until 96 h post infusion of the bacteria
(Bannerman et al. 2004a). Combined, these results suggest IL-1 plays a significant role
in S. uberis and E. coli mastitis but not Serratia marcescens mastitis.
Interleukin-6 is synthesized primarily from macrophages and epithelial cells that
have interacted with bacteria directly or with bacterial toxin via TLRs (Rainard and
Riollet 2003; Zhang and Issekutz 2002). IL-6 is involved in the massive influx of
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neutrophils into the mammary gland. IL-6 binding to endothelial cells induces the
release of interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) to recruit
neutrophils and cause increased expression of adhesion molecules to aid in neutrophil
extravasation (Romano et al. 1997). Moyes et al. (2009) demonstrated that during S.
uberis mastitis, IL-6 transcripts were increased 430-fold, which may contribute to
increased levels of IL-6 protein witnessed during mastitis incidence. IL-6 typically
follows increased TNF-α and IL-1 concentrations at approximately 14 h post E. coli
infection (Nakajima et al. 1997; Shuster et al. 1997). LPS injection resulted in a rapid
increase in IL-6 concentrations occurring as early as 2.5 h (Shuster et al. 1993).
Increased levels of IL-6 are also seen in sera and milk after infection with other
coliforms including: E. coli, Klebsiella oxytoca, Pseudomonas aeruginosa, and
Enterobacter spp. (Nakajima et al. 1997). Together, this suggest that the degree of IL-6
response is dependent on the causative agent.
ELR+ Chemokines
A family of glutamic acid-leucine-arginine+ (ELR+) chemokines includes: growth
related oncogene (GRO)-α, GRO-β, GRO-γ, epithelial-derived neutrophil-activating
peptide-78 (ENA-78), granulocyte chemotactic protein-2 (GCP-2), neutrophil-activating
peptide-2 (NAP-2), and interleukin-8 (IL-8). The nomenclature of ELR+ chemokines are
summarized in Table 7. These chemokines share a C-X-C motif in their structures and
are linked to both inflammatory and reparative functions (Miller and Krangel 1992;
Oppenheim et al. 1991). An important three amino acid sequence, E-L-R, directly prior
to the first cysteine residue of the C-X-C motif is linked to their ability to induce or inhibit
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migration of neutrophils (Clark-Lewis et al. 1993; Clark-Lewis et al. 1995; Hébert et al.
1991).
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Table 7: List of standardized and common names of ELR+ chemokines.

Standardized Name
CXCL1
CXCL2
CXCL3
CXCL5
CXCL6
CXCL7
CXCL8

Common Names
GRO-α, NAP-3
GRO-β, MIP-2
GRO-γ, MIP-2b
ENA-78
GCP-2
NAP-2, PPBP
IL-8, GCP-1, NAP-1, NCF
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Growth Related Oncogenes
Growth related oncogene-α (GRO-α, NAP-3, CXCL1) is expressed by two cell
types: epithelial cells, and macrophages. Bovine mammary epithelial cells secrete
basal levels of GRO-α at all times (Lahouassa et al. 2007). E. coli stimulation increases
GRO-α concentrations steadily until at least 24 h post exposure (Lahouassa et al.
2007). Upon stimulation with S. aureus, levels increase slightly by three h post
exposure and return to basal levels by 24 h (Lahouassa et al. 2007). Unstimulated
human mammary epithelial cells (Maheshwari et al. 2003), cultured human bronchial
epithelial cells (Marshall et al. 2001) and human vaginal epithelial cells (Peterson et al.
2005) increase GRO-α production in response to infection. Upon stimulation of lung
alveolar macrophages with E. coli endotoxin, GRO-α is released (Goodman et al. 1998).
These indicate that GRO-α is released naturally and in response to a variety of bacterial
stimuli.
Growth related oncogene-β (GRO-β, MIP-2, CXCL2) also is expressed by
epithelial cells and macrophages. After stimulation with E. coli, cultured bovine
mammary epithelial cells release GRO-β and continue for at least 24 h (Lahouassa et
al. 2007). S. aureus stimulation resulted in increases similar to those observed by E.
coli stimulation but did not surpass E. coli stimulation concentrations (Lahouassa et al.
2007). Similarly, GRO-β is released from unstimulated human mammary epithelial cells
(Maheshwari et al. 2003), S. aureus stimulated human vaginal epithelial cells (Peterson
et al. 2005), and E. coli endotoxin stimulated lung alveolar macrophages (Goodman et
al. 1998).
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Growth related oncogene-γ (GRO-γ, MIP-2b, CXCL3) is expressed by several
cell types such as epithelial cells, macrophages, monocytes, and neutrophils. Bovine
mammary epithelial cells constitutively express GRO-γ during uninfected and infected
states (Rainard et al. 2008), as do human mammary epithelial cells (Maheshwari et al.
2003). S. aureus stimulated human vaginal epithelial cells also increase GRO-γ
concentrations (Peterson et al. 2005). Furthermore, bacterial endotoxin and/or
inflammatory cytokines, TNF-α and IL-1 stimulate GRO-γ release from lung alveolar
macrophages, monocytes, and neutrophils (Goodman et al. 1998; Haskill et al. 1990;
Iida and Grotendorst 1990).
The GRO chemokines have the ability to induce neutrophil migration (Geiser et
al. 1993; Haskill et al. 1990; Lahouassa et al. 2007; Rainard et al. 2008; Youngs et al.
1997). Specifically, GRO-γ had been identified as the largest recruiter of neutrophils
from bovine milk during both uninfected and infected states (Rainard et al. 2008).
These chemokines also have been associated with events subsequent to neutrophil
migration such as: neutrophil exocytosis, neutrophil shape changes, increases in
intracellular Ca++ levels, and neutrophil respiratory burst (Ahuja and Murphy 1996;
Geiser et al. 1993; Lahouassa et al. 2007; Rainard et al. 2008). GRO-γ is unique in
possessing some effect on basophils, having the capability to induce chemotaxis and
increases in intracellular Ca++ concentrations (Geiser et al. 1993). Overall, the GRO
chemokines possess properties very similar to that of IL-8
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Epithelial-derived Neutrophil-activating Peptide-78
Epithelial-derived neutrophil-activating peptide-78 (ENA-78, CXCL5), as its name
suggests, was first discovered in an epithelial cell culture line (A549) (Walz et al. 1991),
but also is released from macrophages and monocytes (Allmann-Iselin et al. 1994).
Basal levels of ENA-78 are released from cultured epithelial cells (A549) at all times
(Walz et al. 1991). Increased release of ENA-78 was not induced by LPS or other
bacterial endotoxins, but it is massively induced by pro-inflammatory cytokines such as
TNF-α and IL-1 (Walz et al. 1991).
Like its family members, ENA-78 is primarily known for its ability to attract
neutrophils. In bovines, ENA-78 was first characterized from lung tissue (Allmann-Iselin
et al. 1994). The potency of ENA-78 as a neutrophil chemoattractant was similar to that
of IL-8 at most concentrations (0.1-100nmol/L) (Allmann-Iselin et al. 1994; Walz et al.
1991). However, IL-8’s function was approximately ten times higher at the more
elevated concentrations (100 and 1000nmol/L) (Allmann-Iselin et al. 1994; Walz et al.
1991). Bovine ENA-78 also was comparable to IL-8 at inducing neutrophil aggregation
(Allmann-Iselin et al. 1994). However, ENA-78 activated the release of intracellular
Ca++ more efficiently than low concentrations of IL-8 (1nmol/L) but comparable at higher
concentrations (Allmann-Iselin et al. 1994; Walz et al. 1991). ENA-78 also mediates
elastase release by neutrophils in a similar dose dependent manner (Walz et al. 1991).
Lastly, ENA-78 was able to induce a shape change in neutrophils similar ( i.e.: fast,
prolonged, dose dependent) to IL-8 (Allmann-Iselin et al. 1994). All together, these
data suggest ENA-78 has comparable capabilities to IL-8, but is not as potent.
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Neutrophil-activating Peptide-2
Neutrophil-activating peptide-2 (NAP-2,PPBP, CXCL7) is a 70 amino acid
cleavage product of the platelet α-granule component of platelet basic protein (PBP)
and its precursor, connective tissue-activating peptide-III (CTAP-III) (Walz and
Baggiolini 1989). The cleavage action of a monocyte released protease generates
NAP-2 from its platelet derived precursor (Walz and Baggiolini 1990). The release of
NAP-2 is often in response to stimuli such as E. coli LPS (Walz and Baggiolini 1989).
Like its family members, NAP-2 can induce elastase release, increased levels of
intracellular Ca++, neutrophil chemotaxis, and neutrophil exocytosis (Loetscher et al.
1994; Walz et al. 1989). The NAP-2 induced changes were considered completely
independent of its precursors, PBP and CTAP-III, because neither of the precursors
were capable (Walz et al. 1989). NAP-2 also increases microvascular permeability to
aid in neutrophil extravasation (Van Osselaer et al. 1991). However, NAP-2 is
considered a less potent activator than IL-8 but still capable of recruiting neutrophils and
aiding in their migration to the site of infection (Walz et al. 1989).
Interleukin-8
Interleukin-8 (IL-8, GCP-1, NAP-1, NCF, CXCL8) is an immune-related
chemokine. Interleukin-8 is released in response to a variety of cell stressors such as
reactive oxygen species, bacterial fragments, and pro-inflammatory cytokines
(Baggiolini and Clark-Lewis 1992; Bautista and Spitzer 1990; DeForge et al. 1992;
DeForge et al. 1993; Grob et al. 1990; Matsushima and Oppenheim 1989; Seitz et al.
1991). An activator responsible for IL-8 release is ROS. Reactive oxygen species
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include superoxides, peroxides, and hydroxyl radicals. ROS are produced as
intermediates or byproducts of normal cellular functions (Liu et al. 2002) including
bacteria initiated leukocyte phagocytic processes (Bautista and Spitzer 1990).
Superoxide anions (O2-) are converted to hydrogen peroxide (H2O2) which then can be
broken down to a hydroxyl radical (OH·). Each by product has been associated with
high levels of damage in surrounding tissues (Halliwell 1991). Increased concentrations
of ROSs directly influence the production and release of IL-8 through the regulation of
gene expression (DeForge et al. 1993). Furthermore, LPS stimulated whole blood
treated with ROS scavengers leads to a significant reduction in the amount of IL-8
present within blood with no reduction in cell viability or the pro-inflammatory cytokines
TNF-α, IL-1, or IL-6 (DeForge et al. 1992).
Bacterial fragments such as LPS, upon binding to TLR4 activate IL-8 release
(Bautista and Spitzer 1990; Grob et al. 1990; Seitz et al. 1991). Pro-inflammatory
cytokines such as TNF-α, IL-1, and IL-6, which are released in response to infection
induce IL-8 release (Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Matsushima
and Oppenheim 1989; Seitz et al. 1991). All of these stressors (reactive oxygen
species, bacterial fragments, and pro-inflammatory cytokines) are indicators of an
inflammatory state, which provides a link between the inflammatory state and IL-8.
After IL-8 is released, it is responsible for key immune responses. Perhaps the
most well documented function of IL-8 is its ability to stimulate migration of specific cell
types. This ability allows recruitment of leukocytes, especially neutrophils, to the site of
infection and allows the host to be more efficient in fighting off infection. Once bound to
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the neutrophil, IL-8 induces three main changes in neutrophils. First, a conformational
change allows adherence to endothelial cells which is essential for migration out of the
blood vessel to infected tissues (Baggiolini and Clark-Lewis 1992). Second, exocytosis
of soluble storage proteins from secretory vesicles and granules cause increased
expression of adhesion molecules such as CD11b,c and CD18 that are essential for
adhesion to endothelial cells (Baggiolini and Clark-Lewis 1992). Congruently,
macrophages are activated to produce and release cytokines as well as enhance
macrophage phagocytosis of IgG-opsonized bacteria (Soehnlein et al. 2008), and
opsonization of pathogens like Staphylococcus aureus (Heinzelmann et al. 1998). Last,
activation of NADPH-oxidase helps generate ROS used to combat foreign pathogens at
the site of infection (Baggiolini and Clark-Lewis 1992).
Another function of IL-8 is the regulation of host cell survival, typically by
prohibiting apoptosis and extending the life-span of neutrophils. This would allow them
to fight infections longer (Kettritz et al. 1998; Shamaladevi et al. 2009). Interleukin-8
also modulates chemokine and cytokine profiles to aid in perpetuating the inflammatory
state (Soehnlein et al. 2008). Interleukin-8 has two specific membrane bound
receptors, CXCR1 and CXCR2, which are G-protein coupled receptors (Ahuja and
Murphy 1996; Lee et al. 1992; Murphy 1994). Upon IL-8 binding to its receptors, it
activates G-protein coupled responses. Downstream effects of G-protein signaling
include two main signaling pathways: cyclic adenosine monophosphate (cAMP) and
phosphatidylinositol. Both of these pathways are responsible for a wide variety of
biological responses that range from hormone to inflammatory signaling (Baggiolini and
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Clark-Lewis 1992). Furthermore, gene products influenced by E. coli based mastitis are
those associated with G-protein coupled signaling (Buitenhuis et al. 2011; Mitterhuemer
et al. 2010; Rinaldi et al. 2010). IL-8 is a key component of the immune response that
amplifies the pro-inflammatory signals released from the site of infection.
Several different cell types including: epithelial cells, endothelial cells, fibroblasts,
macrophages, dendritic cells, and neutrophils produce IL-8 in order for IL-8 to respond
to stressors and induce the necessary downstream effects. Cultured primary mammary
epithelial cells and MAC-T cells demonstrated IL-8 release in response to E. coli LPS,
E. coli, and S. aureus stimulation (Boudjellab et al. 1998; Lahouassa et al. 2007).
Further examination with the MAC-T cell line revealed LPS binding of TLR4 caused the
release of TNF-α and IL-1, which causedIL-8 release (Boudjellab et al. 2000; Fitzgerald
et al. 2007). The ability of epithelial cells to initiate the immune response is critical
because they are often the first cell type encountered by invading bacteria. Cultured
human endothelial cells (Strieter et al. 1989a) and fibroblasts (Strieter et al. 1989b) also
release IL-8 in response to LPS, IL-1, and TNF-α stimulation. Bovine macrophages, the
sentinels of the mammary gland, release IL-8 in response to a variety of proinflammatory cytokines, bacterial fragments and toxins, and phagocytosis (Craven
1983). Lastly, neutrophils, although commonly viewed as primarily responding to IL-8
released from other cells, can release IL-8 themselves in response to phagocytosis,
LPS, and human/bovine lactoferrin. This perpetuated neutrophil recruitment to the site
of infection via subsequent binding to the membrane bound receptors, CXCR1 and
CXCR2, expressed on neutrophils (Bazzoni et al. 1991; Shinoda et al. 1996).
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Upon infection within the mammary gland an increase in IL-8 was observed.
Moyes et al. (2009) revealed that S. uberis induced mastitis caused a 1054-fold
increase in IL-8 gene transcription, making it the most significantly altered gene in this
study. Experimental intramammary challenge with E. coli also showed a significant
increase in IL-8 mRNA production compared to non-challenged glands (Buitenhuis et al.
2011). A second E. coli study demonstrated IL-8 mRNA was up-regulated 120-fold in
infected mammary tissue (Mitterhuemer et al. 2010). In similar findings, the IL-8 gene
transcripts persisted for at least 24 h post E. coli infusion (Rinaldi et al. 2010).
The increase in gene transcripts most likely contributes to the increase in protein
expression observed in following studies. Experimental challenge with S. uberis
produced a sustained elevation in milk IL-8 levels for over 96 h post infusion
(Bannerman et al. 2004a). The increased levels of IL-8 associated with E. coli mastitis
follow the same pattern as S. uberis, with an initial surge in whey. IL-8 levels steadily
decrease as the infection clears (Riollet et al. 2000; Shuster et al. 1997). In contrast,
when S. aureus mastitis was experimentally induced, IL-8 was not detected in the whey.
This pattern was consistent across six cows and suggests that pathogen specificity or
pathogen action may play a significant role in the cytokines released (Riollet et al.
2000). S. marcescens intramammary challenge produced a rapid spike in IL-8 which
tapered off after about 24 h (Bannerman et al. 2004a). Together, these data suggest IL8 is a critical early indicator of an infection state within the mammary gland.
Watanabe at el. (2008) showed that injecting recombinant bovine IL-8 into the
mammary gland produced a wide variety of effects. The most significant effects were a
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dramatic increase in the number of somatic cells, specifically neutrophils, present in the
mammary gland and in the milk, increased concentration of antibodies, and the amount
serum albumin in milk in comparison to a gland not infused with IL-8. This suggests
that IL-8 has the capability to alter the integrity of the milk-blood barrier allowing
increased concentrations of somatic cells and serum proteins to enter the milk and
dramatically increase the neutrophil population within the mammary gland (Watanabe et
al. 2008).
CXCR1 and CXCR2
The CXCR1 and CXCR2 genes are located on chromosome 2q and each
consists of a coding region of approximately 1000bp (Pighetti and Rambeaud 2006).
The CXCR1 gene is located on chromosome 2q, on the opposite strand, and close to
the q telomere, whereas the CXCR2 gene is located on chromosome 2q but closer to
the centromere (Pighetti and Rambeaud 2006). In addition to their close proximity in
the genome, the receptors’ share a high degree of homology. The mRNA transcripts
display 95% homology in their nucleotide sequences and the completed peptides share
84% homology, including 100% homology in the last, 50 amino acids of the C-terminus
(Lahouassa et al. 2008; Pighetti and Rambeaud 2006).
Despite the homology between the two receptors, CXCR1 and CXCR2 display
differential binding characteristics. CXCR1 has two ligands, IL-8 and the rarely seen
granulocyte chemotactic protein-2 (GCP-2), whereas CXCR2 is more promiscuous.
CXCR2 binds IL-8 with high affinity, like CXCR1, but it also binds GRO-α, β, γ, ENA-78,
and NAP-2, which are all functionally similar to IL-8 (Ahuja and Murphy 1996; LaRosa et
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al. 1992; Lee et al. 1992). Both receptors are part of the G-protein-linked seven
transmembrane domain receptor family and possess the characteristic three
intracellular loops (Murphy 1994). The extracellular amino-terminus of the receptor
dictates ligand binding specificity (LaRosa et al. 1992). The intracellular carboxylterminus initiates receptor internalization and cellular signaling pathways via its coupled
G-proteins (Ben-Baruch et al. 1995; Richardson et al. 2003).
CXCR1 and CXCR2 receptors are expressed on neutrophils (Ahuja and Murphy
1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon 2001; Paape et al. 2002a;
Sprenger et al. 1994). The expression of CXCR1 has also been documented on other
immune related cells including: dendritic cells (Sallusto et al. 1998), natural killer cells
(Berahovich et al. 2006), CD4+ T-cells (Gasser et al. 2006), and CD8+ T-cells (Takata
et al. 2004). Less has been documented about their expression on non-immune cell
populations. However, CXCR1 has been shown to be expressed on human mammary
stem cells (Ben-Baruch 2003) and endothelial cells (Murdoch et al. 1999), as well as
several cancer cell types including: breast cancer cells (Ben-Baruch 2003; CharafeJauffret et al. 2009), prostate cancer cells (Shamaladevi et al. 2009), and malignant
melanoma cells (Gabellini et al. 2009). The other receptor, CXCR2 is expressed on
endothelial cells and some epithelial cells (Dwinell et al. 1999; Miller et al. 1998; Wislez
et al. 2006). In bovine mammary tissue, it is unknown which cell populations express
these two receptors and thus which cell types can respond to IL-8 and its functionally
similar family members.
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These receptors have been studied in a variety of species. The bovine CXCR1
and CXCR2 genes have significant amounts of synergy with the corresponding genes in
other species including humans and mice (Grosse et al. 1999; Lahouassa et al. 2008;
Pighetti and Rambeaud 2006; Sonstegard et al. 1997). Within the human CXCR1 gene,
several SNPs have been identified and some have been associated with susceptibility
to inflammatory diseases (Kato et al. 2000; Renzoni et al. 2000). A goal of the cattle
industries is to improve general herd health using genetic selection processes. In
efforts to identify potential marker candidates, studies hunted for SNPs within immune
related genes, including the genes for CXCR1 and CXCR2. A study by Grosse et al.
(1999) identified four key SNPs in the CXCR1 gene. These SNPs were originally
reported in CXCR2 but, close homology between the sequences of the bovine CXCR1
and CXCR2 receptors caused confusion with the original annotation within public
databases (Lahouassa et al. 2008; Pighetti and Rambeaud 2006). The majority of
papers concerning bovine CXCR1 that were published prior to the discovery of the
incorrect annotation in 2006 refer to CXCR2 when they are actually CXCR1. Further
examination of these SNPs revealed their presence within both Angus and Herford
breeds as well as their crossbreeds (Heaton et al. 2001). Upon examining these same
SNP profiles in Jersey and Holstein dairy cattle breeds, all four SNPs were observed
and a fifth SNP was identified (Youngerman et al. 2004a). Leyva-Baca et al. (2008)
also looked at CXCR1 SNPs (c.-20-1648, c.-20-1586, c.+291, and c.+735) and the
relationship to mastitis in Holstein dairy cows. Of these identified SNPs, only c.-201586 showed an association with high somatic cell scores (SCS) and was limited to the
first and second lactations (Leyva-Baca et al. 2008).
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Our lab further examined the CXCR1 gene in dairy cattle and determined an
association between mastitis and certain SNPs in the bovine CXCR1 gene. Originally,
five SNPs were identified: +612, +684, +777, +858, and +861 (Youngerman et al.
2004b). However, all were synonymous substitutions except +777, which induced a
glutamine to histidine change (Youngerman et al. 2004b). Subsequent studies
discovered the +777 SNP was linked to increased subclinical and clinical cases of
mastitis (Youngerman et al. 2004a). These initial studies led to a more comprehensive
examination of polymorphisms in the CXCR1 gene and the naming conventions
changed to reflect the Human Genome Variation Society Guidelines (Table 8). The
study discovered a total of 11 polymorphisms within the coding region: +291, +365,
+570, +621, +735 (formerly +777), +816 (formerly +858), +819 (formerly +861), +980,
+995, +1008, and +1068 (Pighetti et al. 2012). Of these, six are synonymous, four
(+365, +735, +980, +995) induced amino acid changes and one (+621) induced an
early stop codon (Pighetti et al. 2012). The +365 SNP is located on the first intracellular
loop and has close proximity to the G-protein coupled receptor that allows for the signal
cascade (Leong et al. 1994). Similarly, the +735 SNP is located on the third
extracellular loop and has been linked to a variety of downstream effects of IL-8 binding
that have been studied by our lab (Rambeaud et al. 2006; Rambeaud and Pighetti
2007; Rambeaud and Pighetti 2005; Youngerman et al. 2004a).
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Table 8: A partial list of bovine CXCR1 SNPs indicating current and previous naming
conventions (Pighetti et al. 2012).

Standardized SNP Positiona
c.-20-1648
c.-20-1586
c.+291
c.+365
c.+621
c.+735
c.+816
c.+819
c.+980
c.+995

SNP Position in Prior Publications
-1830
-1768
+344

+777
+858
+861

a

Based on Human Genome Variation Society Guidelines in reference to the cDNA and
the position relative to the transcription start site within the genome.
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The +735 SNP involves a G to C switch on the gene that results in a glutamine to
histidine change in the amino acid structure of the CXCR1 receptor. Cows with the CC
genotype have displayed increased cases of subclinical mastitis (Youngerman et al.
2004a), decreased calcium signaling upon IL-8 binding (Rambeaud and Pighetti 2007),
decreased neutrophil migration (Rambeaud and Pighetti 2005), ROS generation from
neutrophils to aid in bactericidal activities (Rambeaud et al. 2006) and increased
neutrophil survival (Rambeaud et al. 2006). Other studies have demonstrated only a
tendency for the +735 SNP to be associated with SCS that are typically seen in
conjunction with incidences of subclinical mastitis (Beecher et al. 2010; Goertz et al.
2009; Leyva-Baca et al. 2008). These differences are most likely due to sample size,
since the Youngerman (2004a) study had a small sample size (n=88) and the Beecher
(2010), Goertz (2009), and Leyva-Baca (2008) studies had large sample sizes (n=246,
n=749, n=338 respectively). We hypothesize that cows with the CC genotype at
CXCR1 c.+735 are at a disadvantage for fighting off infections due to the impaired
immune functions. Cows that have the GG genotype displayed normal levels of
neutrophil survival, migration, ROS generation and internal calcium signaling, and have
been associated with a lower instance of subclinical mastitis (Youngerman et al. 2004a).
Those cows expressing the heterozygous genotype (GC) display a mixture of these
responses and thus have functions that lie between normal and impaired levels of ability
(Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005;
Youngerman et al. 2004a).
SNPs +980 and +995 occur close to the C-terminus of the receptor (Pighetti et al.
2012). The +980 position has been shown to influence ligand binding, migration, as
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well receptor internalization of the CXCR2 receptor (Raman et al. 2010). This
information is relevant due to the fact that the C-termini of the bovine CXCR1 and
CXCR2 receptors are virtually identical (Lahouassa et al. 2008). Lastly, the +621 SNP
that induces an early stop codon is located within the second intracellular loop of the
receptor. Regardless of whether this switch causes partial or no receptor expression,
the +621 SNP has potential to influence function of the CXCR1 receptor.
Individual tagSNPs were combined to form amino acid based haplotypes (Table
9) (Pighetti et al. 2012). A tagSNP represents a group of SNPs in high linkage
disequilibrium or non-random allele association, increasing the probability that SNPs will
be inherited together. Three amino acid haplotypes (VWHKH, VWHRR, AWQRR)
represented more than 99% of the sample bovine population (n=88) (Pighetti et al.
2012). Knowledge of the potential effects of each SNP mutation allows for the
conclusion that VWHRR homozygous cows may be impaired in their abilities to
effectively respond to bound ligand compared to the other haplotype combinations. The
existence of three dominant haplotypes within the sample population suggests looking
at haplotypes instead of individual SNPs within the receptor’s gene may provide a more
comprehensive understanding of the cow’s potential to fight off mastitis. Haplotype
selection may also streamline efforts for genetic selection by increasing the number of
identifying SNPs could allow for more specific selection of cows with a better genetic
background relative to CXCR1.
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Table 9: Relationships among CXCR1 c.+735 allele, tagSNP haplotype, and amino acid
haplotype (Pighetti et al. 2012).

+735 Allele
(Former
+777)
735
C
G
C
G

tagSNP Haplotype

Nucleotide
Haplotype

Amino Acid
Haplotype

+621+735+816+980
GCCA
AGCG
GCAG
GGCG

365-621-735-980-995
TGCAA
CAGGG
TGCGG
CGGGG

122-206-245-327-332
VWHKH
AX
VWHRR
AWQRR
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Interleukin-8 receptor expression in bovine mammary tissue.
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Abstract
Mastitis is an ongoing issue in the dairy industry, which often results from a
variety of immune related responses to bacteria in the mammary gland. Many immune
responses are mediated by interleukin-8 (IL-8) and its receptors CXCR1 and CXCR2.
Exposure of the mammary gland to bacteria causes the release of IL-8. Subsequent
binding of IL-8 to its receptors induces immune responses related to host cell survival,
migration and chemokine/cytokine production. These receptors are typically regarded
as being present on immune cells with an emphasis on neutrophils. Within the bovine
mammary gland we hypothesize CXCR1 expression on immune cells and epithelial
cells and CXCR2 expression on immune cells, epithelial cells, and endothelial cells
based on research conducted in other species. To evaluate CXCR1 and CXCR2
expression in bovine mammary gland we used dual immunofluorescence on mammary
tissue sections from 6 Holstein dairy cows in early (5-6d days in milk (DIM)), mid (5999d DIM), and late (>250d DIM) lactation. Results demonstrate CXCR1 and CXCR2
have different patterns of expression. We discovered both CXCR1 and CXCR2
expressed natively in the bovine mammary gland. CXCR1 is expressed by epithelial
cells, some fibroblasts and 10-50% of leukocytes, whereas CXCR2 is present on
epithelial cells and 5-30% of leukocytes. These results indicate that multiple cell types
in the mammary gland express receptors for IL-8 and are capable of responding to IL-8
released in the environment. Greater knowledge of how these cell populations respond
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to IL-8 binding its receptors within the mammary gland could create novel treatment
targets for mastitis.
Introduction
Mastitis costs the dairy industry billions of dollars in lost profits annually (NMC
2005). Mastitis is typically caused by bacteria entering the mammary gland. Once
within the gland, bacteria encounter a variety of cell types, mainly epithelial cells
because they comprise about 70% of mammary gland parenchyma (Capuco et al.
1997). These cells can initiate the immune response when bacterial components such
as lipopolysaccharide (LPS) bind pathogen recognition receptors such as TLR4 on the
cell surface of encountered cells. Upon TLR4 engagement many proinflammatory
cytokines are released including TNF-α and IL-1 (Beutler 2004; Takeuchi et al. 2000).
Interaction of TNF-α and IL-1 with their specific receptors causes the subsequent
release of a second round of immune mediators, which can include ELR+ chemokines
(Boudjellab et al. 2000; Fitzgerald et al. 2007).
The ELR+ chemokines include GRO-α (CXCL1), GRO-β (CXCL2), GRO-γ
(CXCL3), ENA-78 (CXCL5), GCP-1 (CXCL6), NAP-2 (CXCL7) and IL-8 (CXCL8) (Grob
et al. 1990; Lahouassa et al. 2007; Rainard et al. 2008; Walz et al. 1991; Walz et al.
1989). The ELR+ chemokines initiate several immune functions necessary for
combating infection. This includes chemotaxis of neutrophils to the site of infection,
increased expression of adhesion molecules on endothelial cells, neutrophil respiratory
burst, and neutrophil shape change, which is needed for extravasation from blood into
tissues (Allmann-Iselin et al. 1994; Baggiolini and Clark-Lewis 1992; Geiser et al. 1993;
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Grob et al. 1990; Lahouassa et al. 2008; Loetscher et al. 1994). ELR+ chemokines also
mediate host cell survival allowing cells to live longer and fight off infections by
decreasing spontaneous apoptosis (Kettritz et al. 1998). Lastly, chemokine/cytokine
profiles are altered by ELR+ chemokines. This aids in perpetuating the inflammatory
state and the continued increase in neutrophil chemotaxis and survival (Soehnlein et al.
2008).
The ELR+ chemokines bind two specific receptors, CXCR1 and CXCR2. The
CXCR1 receptor binds both IL-8 and GCP-1 with high affinity, but GCP-1 is rarely
observed in vivo (Ahuja and Murphy 1996). The CXCR2 receptor binds all ELR+
chemokines mentioned in the prior paragraph, but has the highest affinity for IL-8 (Ahuja
and Murphy 1996; Lee et al. 1992). These two receptors are expressed on neutrophils
but the expression of these receptors on other cell types is less well studied (Ahuja and
Murphy 1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon 2001; Paape et al. 2002;
Sprenger et al. 1994). In other species CXCR1 expression has been demonstrated on
endothelial cells, mammary stem cells, dendritic cells, natural killer cells, CD4+ T-cells,
CD8+ T-cells, and eosinophils. CXCR2 has more limited expression including
endothelial cells, epithelial cells, and eosinophils (Ben-Baruch 2003; Berahovich et al.
2006; Gasser et al. 2006; Park et al. 2010; Petering et al. 1999; Sallusto et al. 1998;
Takata et al. 2004). Furthermore, receptor expression has been tied to a variety of
cancers (i.e.: malignant melanomas, prostate cancer, and breast cancer) where they
contribute to prolonged cell survival and metastasizing (Ben-Baruch 2003; Gabellini et
al. 2009; Shamaladevi et al. 2009).
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In the bovine mammary gland, little is known about CXCR1 and CXCR2
expression. In this study we evaluated CXCR1 and CXCR2 expression in lactating
bovine mammary tissue through the use of dual immunofluorescence with antibodies
specific to bovine CXCR1, CXCR2 and cell type markers.
Materials and Methods
Animal and Tissue Selection
Tissue samples were obtained from n=6 Holstein dairy cows, two in early
lactation (5-6d days DIM), two in mid lactation (59-99d DIM), and two in late lactation
(248-337d DIM).

From each cow, tissue samples were taken from a healthy quarter

and a quarter infected with Streptococcus uberis, a common mastitis causing pathogen.
Early lactation cow samples were obtained from cows sacrificed as part of a USDANIFA (2011-67015-30168) funded challenge study at East Tennessee Research and
Education Center (ETREC; Knoxville, TN) and the mid and late lactation samples were
obtained from our collaborator Dr. John Lippolis at the USDA-NADC (Ames, IA).
Verification of Antibody Specificity
Dot Blot to Evaluate Specificity of CXCR1 and CXCR2 to Peptides
Antibodies were developed in rabbits against specific amino acid peptides of the
N-termini of bovine CXCR1 (PTEDYDYSPCEISTET) and CXCR2 (MAETKFTSNIEGFC)
which were conjugated to KLH to improve immunogenicity (21st Century Biochemicals,
Inc., Marlboro, MA). These specific amino acid segments were synthesized (Peptide
2.0, Inc., Chantilly, VA and 21st Century Biochemicals, Inc., Marlboro, MA) and used to
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verify antibody specificity between CXCR1 and CXCR2 on a PVDF membrane using a
dot blot assay. From initial peptide stocks of 1mM, peptides were diluted 1:40 (25µM),
1:200 (5µM), and 1:1000 (1µM) in PBS and applied to the PVDF membrane using a
vacuum. A control (no peptide) also was included. The membranes then were blocked
using PBS + 1% non-fat dry milk + 0.1% Tween-20 for 20 min at room temperature.
After a series of two washes in PBS, the desired primary antibody: rabbit anti-bovine
CXCR1, CXCR2, or pre-immunization sera (1:1000) was applied to the membrane and
allowed to incubate at room temperature for 30 min with shaking. The membrane was
washed twice in PBST [PBS + 0.1% Tween-20] and once in PBS to remove excess
primary antibody. Next, stabilized goat anti-rabbit HRP-conjugate secondary antibody
(Pierce 34095, Rockford, IL; 1:5000) was incubated with the membrane for 30 min at
room temperature with shaking. Lastly, after another two washes in PBST and one in
PBS, the membrane was developed with a 1:1 solution of peroxide buffer and
luminol/enhancer solution (Pierce 34095, Rockford, IL). Pictures were taken using
Alpha Innotech Fluorchem imaging equipment and software. Various combinations of
CXCR1 and CXCR2 antibodies and peptides were tested together using this method to
ensure that cross-binding was not observed. Results indicate that cross-binding does
not occur between antibody and pre-bleed combinations, CXCR1 antibody and CXCR2
peptide, or between CXCR2 antibody and CXCR1 peptide suggesting antibody
specificity (Figure 4).
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Figure 4: Dot blots indicating bovine CXCR1 and CXCR2 antibody specificity. (A)
Specific CXCR1 antibody binds CXCR1 peptide with increasing concentrations of
peptide. (B) CXCR2 antibody does not bind CXCR1 peptide. (C) CXCR1 peptide does
not interact with CXCR1 pre-bleed sera. (D) Specific CXCR2 antibody binds CXCR2
peptide with increasing concentrations of peptide. (E) CXCR1 antibody does not bind
CXCR2 peptide. (F) CXCR2 peptide does not interact with CXCR2 pre-bleed sera.
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Bovine Mammary Gland Protein Lysate Preparation
Approximately 100mg of frozen tissue was lysed in modified RIPA buffer (50mM
TrisHCl pH 7.4, 150mM NaCl, 0.1% TritonX100, 5mM EDTA supplemented with DTT
(1mM) and inhibitors (Roche, 04693159001, Indianapolis, IN) by use of a rotor-stator
homogenizer (3 bursts of 10 s) followed by sonication (3 bursts of 10 s) on ice.
Resulting lysates were cleared by centrifugation at 15,000g for 3 min at 4°C and stored
at -80oC. Lysates from mouse liver and mammary tissue of all six cows were prepared.
For each lysate, concentration was determined using a BCA Protein Assay (Pierce,
Rockford, IL). (Performed by Leszek Wojakiewicz)
Western Blot
Twelve percent SDS-PAGE gels with electrophoretically resolved protein lysates
(50µg per lane) were blotted onto PVDF membrane using Trans-Blot SD (Bio-Rad,
Hercules, CA). MagicMark (Bio-Rad, Hercules, CA) was used as the molecular weight
marker. Semi-dry blotting was performed at constant current of 60mA for 1 h in CAPS
(for catode 1X CAPS + 1%SDS; for anode 1X CAPS +15% methanol) buffer system.
Detection of both CXCR1 and CXCR2 was carried out using custom affinity purified
polyclonal rabbit antibodies (IgG) raised against specific peptides described earlier (21st
Century Biochemicals) with original concentrations of 0.019mM for anti-CXCR1 and
0.0098mM for anti-CXCR2. Prior to probing, blots were pre-blocked overnight at 4oC in
TBST buffer supplemented with 10% casein blocking reagent (Roche, 11921673001,
Indianapolis, IN). Next they were incubated in TBST buffer with 5% casein blocking
reagent and primary antibody at 1:200 dilution at room temperature on a rocking
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platform, then washed three times for 15 min with cold TBST at room temperature on a
rocking platform. This was followed by detection of primary antibody using a Femto
detection kit (Pierce, 34095, Rockford, IL). Blots were incubated with goat anti-rabbit
antibody conjugated to HRP (TBST, 5% casein blocking reagent, antibody at 1:10,000)
for 45 min at room temperature on a rocking platform, washed three times for 15 min in
cold TBST and incubated in 1mL of combined HRP substrate and enhancer for 1 min.
Freshly air-dried blots were imaged on Alpha Innotech Fluorchem imaging equipment
and software with exposure times ranging from 1-20 min. For experiments using primary
antibodies pre-blocked with specific peptides, solutions containing those antibodies
supplemented with 20µM specific peptide or equal volume of water, but without casein
blocking reagent were pre-incubated 30 min at room temperature on a nutator, then
supplemented with blocking reagent and used in protocol outlined above. (Performed
by Leszek Wojakiewicz)
Preparation of Tissue Section Slides
Using plastic molds, approximately 1cm by 1cm pieces of mammary tissue
stored at -80°C were embedded in optimal cutting temperature compound (OCT) using
liquid nitrogen to the solidify mold. The tissue containing molds then were sliced to 6µm
thick using a cryostat and placed on frost plus slides (Fisher 12-550-18, Pittsburg, PA).
Slides were immediately fixed in -20°C acetone for 5 min and allowed to air dry. Slides
were stored frozen at -80°C until time of staining.
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Dual Immunofluorescence Staining
Slides were first brought to room temperature for 30 min, then fixed in -20°C
acetone for 5 min, washed twice in PBST and then blocked using a sera blocking
solution (PBS + 5% goat serum (Thermo Scientific, Rockford, IL) + 5% horse serum
(Oxoid, Basingstoke, NH)) for 20 min with shaking. Next, slides were washed once in
PBST and then incubated with the primary antibody combination (Table 10) overnight
(15-18 hours) at 4°C with shaking in a mini-humidifier. Slides that received preimmunization sera or no primary antibody also were included to serve as negative
controls. Following overnight incubation, slides were washed three times in PBST and
then incubated with secondary antibody combinations (Table 10) for 1 hour at room
temperature, in the dark, with shaking in a mini-humidifier. Again, slides were washed
three times in PBST and then counterstained for 5 min with 4,6-diamidino-2phenylindole (DAPI) (300nM) (Invitrogen D3571, Grand Island, NY) at room
temperature and washed twice more in PBST. A drop of mounting media (Vector H1000, Burlingame, CA) was applied and a coverslip added followed by clear nail polish
to seal the slide. Microscopy was performed using a Leica SP2 laser scanning confocal
microscope and corresponding software. Images were taken of one area representative
of the entire tissue section. Percentages of positive staining cells were determined by
visual count of cells present within each image and averaged across all cows.
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Table 10: Primary and secondary antibodies used for dual immunofluorescence.

Name
CD45
(CACTB51A)
Connexin-43
(2/Connexin43)

Cell Type
Leukocytes

Source
VMRD, Inc.
0491-0506
BD
Transduction
Laboratories
610062
Santa Cruz
Biotechnology
SC-81714
Dako M7020

Isotype
IgG2a

Species
Murine

Dilution
1:500

IgG1

Murine

1:500

PanCytokeratin
(AE1/AE3)
Vimentin
(Vim3B4)
CXCR1

Epithelial
cells

IgG1

Murine

1:30

IgG2a

Murine

1:100

Sera

Rabbit

1:1000

Sera

Rabbit

1:1000

--

21st Century
Biochemicals
21st Century
Biochemicals
Vector DI-1549

CXCR2

--

DyLight 549
Goat-antirabbit IgG
(H+L) (GAR)
DyLight 488
Horse-antimouse IgG
(H+L) (HAM)

IgG

Goat

1:1000

--

Vector DI-2488

IgG

Horse

1:1000

Myoepithelial
cells

Fibroblasts
--
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Results
Western blots of mammary whole cell lysates from each cow were used to
determine the specificity of bovine CXCR1 and CXCR2 antibodies. The CXCR1 blot
displayed multiple positive staining bands in both bovine mammary gland and mouse
liver (Figure 5 A). However, a band between 50 and 60kDa was present for bovine
mammary gland but absent for mouse liver indicating CXCR1 specificity for this band in
bovine mammary gland. The specific CXCR1 band between 50 and 60kDa was present
across all cows with some variation in level of expression based on band density
(Figure 5 B). The CXCR2 blot contained multiple bands but one band at approximately
60kDa was more dominant and observed for both bovine mammary gland and mouse
liver lysates (Figure 6 A). Blocking of antibodies with CXCR2 peptide decreased or
eliminated this band indicating this band was specific and cross-reacted with mouse
CXCR2. The dominant CXCR2 band was present across all cows (Figure 6 B).
CXCR1 is expressed on mammary epithelial cells (Figure 7 C, D). CXCR1
staining (red) is concentrated basally on alveolar epithelial cells, and epithelial staining
(green) is concentrated apically on alveolar epithelial cells. Dual expression is observed
on alveolar epithelial cells from both uninfected and infected tissues (Figure 7 C, D).
Myoepithelial cells, often observed as green punctate cells, did not express CXCR1 as
indicated by Figure 7 E, F. CXCR1 is expressed on some fibroblasts in both infected
and uninfected tissues (Figure 7 G, H), where dual expression is observed throughout
the stromal regions between alveolar structures. Fibroblast expression of CXCR1 was
not consistent across cows or infection status with 2/6 cows expressing CXCR1 on
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fibroblasts in uninfected quarters and 4/6 cows expressing CXCR1 on fibroblasts in
infected quarters (Table 11). Mammary leukocytes express CXCR1 with approximately
10-50% of leukocytes showing dual expression (Figure 7 I, J).
CXCR2 also is expressed on mammary epithelial cells (Figure 8 C, D). CXCR2
(red) is observed surrounding alveolar epithelial cells and concentrated to bright edges
(Figure 8 C, D; Figure 9). The bright edges sometimes represent one alveolar
epithelial cell and at other times represent a string of adjoining alveolar epithelial cells
(Figure 9). The epithelial marker (green) demonstrates the same staining pattern.
Overlaid images representing both markers display yellow staining indicating dual
expression (Figure 8 C, D). Neither myoepithelial cells (Figure 8 E, F) nor fibroblasts
(Figure 8 G, H) display CXCR2 in uninfected or infected gland tissue. Leukocytes
express CXCR2 in both uninfected and infected quarters with approximately 5-30% of
leukocytes demonstrating dual expression (Figure 8 I, J).
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Figure 5: CXCR1 western blots results demonstrating specific binding of the bovine
CXCR1 antibody for band between 50 and 60kDa. (A) Depicts duplicate lanes of
bovine mammary whole cell lysate (boMG) or mouse liver whole cell lysate (moLiv).
One boMG and one moLiv lysate was suspended in buffer with 1% SDS to ensure
complete membrane breakdown and to optimized receptor binding. The boxed band
between 50 and 60kDa present in boMG is absent from moLiv indicating specificity of
CXCR1 for this band only in bovines. (B) Demonstrates band of interest between 50
and 60kDa is present in mammary whole cell lysates from each of the six cows used
with some variation in level of expression based on band density.
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Figure 6: CXCR2 western blots results demonstrating specific binding of the bovine
CXCR2 antibody for band at approximately 60kDa. (A) Depicts blots with lanes
containing marker, bovine mammary whole cell lysate (boMG), or mouse liver whole cell
lysate (moLiv). The boxed bands at approximately 60kDa in lanes 2 and 3 are removed
via specific peptide blocking of antibody in lanes 5 and 6 and shows affinity for both
bovine and mouse CXCR2. (B) Demonstrates band of interest at approximately 60kDa
is present in mammary whole cell lysates from each of the six cows used.
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Figure 7: CXCR1 expression in bovine mammary gland. Red corresponds to CXCR1
expression and green corresponds to cell specific markers. Yellow indicates dual
expression of both red and green markers and is indicated by arrow heads (◄).
Negative controls receiving only secondary antibody, (A) GAR and (B) HAM,
demonstrated no staining. CXCR1 was expressed on alveolar epithelial cells in both
(C) uninfected quarters and (D) infected quarters. CXCR1 was not observed on
myoepithelial cells in (E) uninfected or (F) infected quarters. CXCR1 was observed on
some fibroblasts in both (G) uninfected quarters and (H) infected quarters. Expression
of CXCR1 was observed on leukocytes in both (I) uninfected quarters and (J) infected
quarters.
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Figure 7: Continued
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Table 11: Presence of CXCR1+ and CXCR2+ staining in specific cell types in lactating
bovine mammary tissue.

Cell Type
IL-8
Receptor
CXCR1
CXCR2

Infection
Status
Uninfected
Infected
Uninfected
Infected

Alveolar
Epithelial
Cells1
6/6
6/6
6/6
6/6

Myoepithelial
Cells1

Fibroblasts1

Leukocytes
(CD45) 1

0/6
0/6
0/6
0/6

2/6
4/6
0/6
0/6

6/6
6/6
6/6
6/6

1

Represents the number of cows that displayed positive staining for each cell
type/receptor combination.
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Figure 8: CXCR2 expression in mammary gland. Red corresponds to CXCR2
expression and green corresponds to cell specific markers. Yellow indicates dual
expression of both red and green markers and is indicated by arrow heads (◄).
Negative controls receiving only secondary antibody, (A) GAR and (B) HAM,
demonstrated no staining. CXCR2 was expressed on alveolar epithelial cells in both
(C) uninfected quarters and (D) infected quarters. CXCR2 was not observed on (E, F)
myoepithelial cells or (G, H) fibroblasts in uninfected or infected quarters. Expression of
CXCR2 was observed on leukocytes in both (I) uninfected quarters and (J) infected
quarters.
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Figure 9: CXCR2 bright edge staining pattern on epithelial cells. Bright edges (◄) are
observed in red CXCR2 stain (left), in green epithelial marker (right) and in composite,
yellow images (middle). This pattern was consistent across all six cows and in both
uninfected and infected glands.
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Discussion
The ligands for CXCR1 and CXCR2 are present in the bovine mammary gland
during both normal and disease states (Rainard et al. 2008). However, we do not know
the ability of native bovine mammary gland cell populations to respond to these ligands.
The objective of this study was to determine which cell populations can respond to
these ligands by evaluating the expression of CXCR1 and CXCR2 on the native cell
populations in the bovine mammary gland. Our results demonstrate alveolar epithelial
cells express CXCR1 and CXCR2 in bovine mammary tissue. Expression of CXCR1
has not been demonstrated on these cells previously, but has been identified on human
mammary stem cells(Ben-Baruch 2003). This suggests the potential for CXCR1
expression on differentiated mammary epithelial cells. CXCR2 expression previously
has been demonstrated on lung alveolar epithelial cells in mice (Wislez et al. 2006).
CXCR1 and CXCR2 also have been witnessed on mammary epithelial tumor cells
(Miller et al. 1998). The expression of these receptors on these various tissue types
allows them to respond to ligands released during and infection state.
The observation of CXCR1 and CXCR2 expression on bovine mammary
epithelial cells suggests these cells are capable of responding to ligands in the
mammary gland environment. For example, when bacteria enter the mammary gland,
epithelial cells are typically the first cell type encountered and activate TLRs that initiate
the immune response causing the subsequent release of inflammatory mediators, TNFα, IL-1, IL-8,GRO-α, β, γ, ENA-78 and NAP-2 (Boudjellab et al. 1998; Boudjellab et al.
2000; Fitzgerald et al. 2007; Lahouassa et al. 2007; Rainard et al. 2008; Walz et al.
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1991; Walz et al. 1989). Binding of IL-8 to CXCR2 has been associated with the ability
of mammary epithelial cell tumors to invade neighboring tissues and metastasize
suggesting a role of this receptor in epithelial cell migration (Nannuru et al. 2011).
Furthermore, metastasized tumors release higher levels of IL-8 then primary tumors
further supporting that the ligand/receptor complex has a strong role in metastasis or
migration of mammary epithelial cells (De Larco et al. 2001). These data suggest the
role of alveolar epithelial cells expressing CXCR1 and CXCR2 may be associated with
increased survival and/or cell migration.
Other evidence linking CXCR1 and CXCR2 expression on alveolar epithelial cells
to migration was demonstrated by direct infusion of IL-8 into the bovine mammary
gland. Direct injection of IL-8 into the gland caused a subsequent increase in serum
proteins within the milk (Watanabe et al. 2008). Serum proteins in the milk suggests IL8 in the gland alters the blood-milk barrier (Watanabe et al. 2008). The infection state
further alters the blood-milk barrier. The breakdown of tight junctions, which are
typically impermeable during lactation to separate milk from tissue, become leaky in
response to TNF and interferon (IFN)-γ that are released in response to infection
(Madara and Stafford 1989). Degradation of the tight junctions frees epithelial cells
from their alveolar structure potentially allowing them to respond to released IL-8 by
migrating. Given these pieces of evidence, future in vitro studies are needed in order to
definitively conclude how bovine mammary epithelial cells respond to CXCR1 and
CXCR2 binding ligand.
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Basally concentrated CXCR1 (Figure 7 C, D) and apically concentrated CXCR2
(Figure 9) expression could be linked to ligand availability. GRO-γ is the predominant
ELR+ chemokine present in normal milk and is a ligand for only CXCR2 which we
witnessed to be apically concentrated (Rainard et al. 2008). IL-8 has very low
concentrations in the milk during an uninfected state (Rainard et al. 2008), suggesting
basal secreted levels of IL-8 may be more concentrated in the parenchyma. The
predominant ligand for CXCR1 is IL-8 and CXCR1 is which we observed to be basally
concentrated. However, further studies focused on patterns of receptor expression on
mammary epithelial cells could definitively decipher this relationship.
As previously stated, CXCR1 demonstrates apical concentration and CXCR2
demonstrates bright edge concentration. The pan-cytokeratin marker used to identify
epithelial cells typically demonstrates luminal and bright edge concentration, thus coexpression is observed with CXCR2 (Figure 9) but not CXCR1 (Figure 7 C, D). The
co-expression of the keratins with CXCR2 appears to be coincidental. Epithelial cell
keratins are often concentrated to luminal edges in secretory structures or structures
subjected to fluid pressures such as ducts and lumens (Schmid et al. 1983; Sun et al.
1979). It is unclear what the role of these luminal and bright edge concentrated keratins
might play in the mammary gland and why CXCR1 does not co-express with them and
CXCR2 does.
Some mammary fibroblasts express CXCR1 (Figure 7 G, H) but not CXCR2
(Figure 8 G, H). Fibroblasts’ traditional role in inflammation has been to repair and
restructure connective tissue (Singer and Clark 1999). In releasing immune related
97

peptides and cytokines, including IL-8, they can initiate the immune response to
invading pathogens or inflammatory cytokines (Kandasamy et al. 2011; Strieter et al.
1989). The expression of CXCR1 on mammary fibroblasts most likely serves the
purpose of increasing migration to the site of infection. Contrasting to our results,
cultured human fibroblasts express CXCR2 but not CXCR1 suggesting expression on
fibroblasts is species and/or tissue type specific (Moser et al. 1993). Future studies
focused on the role of CXCR1 on mammary fibroblasts are needed to demonstrate the
role that this receptor/ligand complex has in mastitis. However, we can speculate
fibroblasts respond to IL-8 by migrating due to the constant remodeling within the
mammary gland in response to an inflammatory state (Zhao and Lacasse 2008) and the
role fibroblasts play in releasing immune peptides and cytokines (Kandasamy et al.
2011).
Leukocytes also express CXCR1 and CXCR2 in the bovine mammary gland.
Our results show CXCR1 expression by approximately 10-50% of CD45+ leukocytes in
the mammary gland and CXCR2 expression on approximately 5-30% of CD45+
leukocytes. As our interest was in overall cell populations that express CXCR1 and
CXCR2, we did not evaluate individual leukocyte populations. However, based on prior
research in other species and tissues, we predict neutrophils and T-cells are the
predominant positive staining populations. These receptors are expressed on
neutrophils (Ahuja and Murphy 1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon
2001; Paape et al. 2002; Sprenger et al. 1994) and binding to its cognate ligand causes
subsequent neutrophil migration to the site of infection and increased survival
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(Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Kettritz et al. 1998; Richardson et
al. 2003). Several other cell types could be expressing these receptors. CXCR1
expression has been witnessed on human dendritic cells (Sallusto et al. 1998), natural
killer cells (Berahovich et al. 2006), CD4+ T-cells (Gasser et al. 2006), CD8+ T-cells
(Takata et al. 2004), and eosinophils (Petering et al. 1999), while CXCR2 expression
has been observed on eosinophils (Petering et al. 1999) and would presumably
influence their migration and survival. Prior studies have determined percentages of
different leukocytes present within both uninfected and infected bovine mammary gland.
Within a healthy gland, the majority are T-cells and antigen presenting cells (Nickerson
and Heald 1982; Shafer-Weaver et al. 1996). Within an infected gland the number of
granulocytes, especially neutrophils, increase and become the dominant leukocyte
population present (Nickerson and Heald 1982). T-cells and antigen presenting cells
have previously demonstrated CXCR1 expression and most likely account for the
leukocytes expressing CXCR1 witnessed in healthy quarters. Granulocytes also
express CXCR1 and most likely account for the CXCR1 expressing cell types in
infected quarters, along with some T-cells and antigen presenting cells. Another large
percentage of leukocytes in the mammary gland are B-cells (Shafer-Weaver et al.
1996). These cells, do not express CXCR1 and most likely account for the fraction of
leukocytes not displaying CXCR1 expression. CXCR2 also was observed on
leukocytes in our study. Previously CXCR2 has been witnessed on neutrophils and
eosinophils, thus the CXCR2 expressing leukocytes are most likely these two cell types.
Future studies examining leukocyte sub-populations will provide greater insight to which
leukocytes are expressing CXCR1 and CXCR2 in the bovine mammary gland.
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CXCR1 and CXCR2 expression were similar between uninfected and infected
states indicating ligand presence determines if the downstream effects are observed.
Basal levels of ELR+ chemokines such as GRO-α, GRO-β, GRO-γ, and IL-8 are
released at all times from mammary epithelial cells, but upon exposure to bacterial
pathogens the levels increase at least 30-fold (Lahouassa et al. 2007; Maheshwari et al.
2003; Rainard et al. 2008). Secreted basal levels most likely contribute to remodeling of
the mammary gland and removal of senescent and damaged cells. Recruitment of
neutrophils and migration of local cell populations that play a large role in remodeling
during lactation and the dry period (Capuco et al. 1997). This remodeling process is
critical to maintaining lactation and efficiency of the bovine mammary gland and
expression of CXCR1 and CXCR2 receptors could contribute to this process. In other
species, CXCR1 and CXCR2 expression is typically linked to either neutrophils or tumor
cells (Ben-Baruch 2003). However, unlike bovines, lactation is temporary. The ELR+
chemokine/CXCR1/CXCR2 axis may facilitate the continual maintenance of the
mammary gland required to perpetuate lactation in bovines. To properly confirm this
tissue samples from a non-bred heifer, a non-lactating dry cow, and cows at various
stages of lactation should be compared.
The results of this study indicate that CXCR1 and CXCR2 are expressed
constitutively on bovine mammary leukocytes and alveolar epithelial cells, with CXCR1
expression on some fibroblasts. We can speculate that these receptors may serve to
induce cell migration, increasing host cell survival and modifying local
chemokine/cytokine profiles based on previous research. These processes are
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essential to the routine maintenance and infection defense of the bovine mammary
gland. However, further in vitro studies will be required to conclusively determine if
these receptors allow mammary gland epithelial cells, fibroblasts and leukocytes to
migrate, survive, and modify chemokine/cytokine.
Acknowledgements
The authors thank members of the ETREC Little River Dairy, as well as Dr. Brian
Whitlock of UTCVM for their aid in collecting tissue samples used in this project. Dr.
John Dunlap of the Division of Biology was essential to this project for his time,
patience, and training for Leica confocal microscopy. This research was supported by
University of Tennessee Ag Research and Microbiology Across Campuses Educational
and Research Venture (MCERV).

101

References
Ahuja, S. K., and Murphy, P. M. (1996). "The CXC chemokines growth-regulated
oncogene (GRO)-α, GRO-β, GRO-γ, neutrophil-activating peptide-2, and
epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the
type B, but not the type A, human interleukin-8 receptor." Journal of Biological
Chemistry, 271(34), 20545-20550.
Allmann-Iselin, I., Car, B. D., Zwahlen, R. D., Mueller-Schüpbach, R., Wyder-Walther,
M., Steckholzer, U., and Walz, A. (1994). "Bovine ENA, a new monocytemacrophage derived cytokine of the interleukin-8 family. Structure, function, and
expression in acute pulmonary inflammation." The American Journal of
Pathology, 145(6), 1382.
Baggiolini, M., and Clark-Lewis, I. (1992). "Interleukin-8, a chemotactic and
inflammatory cytokine." Federation of European Biochemical Societies Letters,
307(1), 97-101.
Ben-Baruch, A. (2003). "Host microenvironment in breast cancer development:
Inflammatory cells, cytokines and chemokines in breast cancer progression reciprocal tumor-microenvironment interactions." Breast Cancer Research, 5(1),
31 - 36.
Berahovich, R. D., Lai, N. L., Wei, Z., Lanier, L. L., and Schall, T. J. (2006). "Evidence
for NK cell subsets based on chemokine receptor expression." The Journal of
Immunology, 177(11), 7833-7840.
Beutler, B. (2004). "Inferences, questions and possibilities in toll-like receptor
signalling." Nature, 430(6996), 257-63.
Boudjellab, N., Chan-Tang, H. S., Li, X., and Zhao, X. (1998). "Interleukin-8 response by
bovine mammary epithelial cells to lipopolysaccharide stimulation." American
Journal of Veterinary Research, 59(12), 1563-1567.
Boudjellab, N., Chan-Tang, H. S., and Zhao, X. (2000). "Bovine interleukin-1 expression
by cultured mammary epithelial cells (MAC-T) and its involvement in the release
of MAC-T derived interleukin-8." Comparative Biochemistry and Physiology,
127(2), 191-199.
Capuco, A. V., Akers, R. M., and Smith, J. J. (1997). "Mammary growth in Holstein cows
during the dry period: Quantification of nucleic acids and histology." Journal of
Dairy Science, 80(3), 477-487.
De Larco, J. E., Wuertz, B. R. K., Rosner, K. A., Erickson, S. A., Gamache, D. E.,
Manivel, J. C., and Furcht, L. T. (2001). "A potential role for interleukin-8 in the
102

metastatic phenotype of breast carcinoma cells." The American Journal of
Pathology, 158(2), 639-646.
Fitzgerald, D. C., Meade, K. G., McEvoy, A. N., Lillis, L., Murphy, E. P., MacHugh, D. E.,
and Baird, A. W. (2007). "Tumour necrosis factor-α (TNF-α) increases nuclear
factor κB (NFκB) activity in and interleukin-8 (IL-8) release from bovine mammary
epithelial cells." Veterinary Immunology and Immunopathology, 116(1–2), 59-68.
Gabellini, C., Trisciuoglio, D., Desideri, M., Candiloro, A., Ragazzoni, Y., Orlandi, A.,
Zupi, G., and Del Bufalo, D. (2009). "Functional activity of CXCL8 receptors,
CXCR1 and CXCR2, on human malignant melanoma progression." European
Journal of Cancer, 45(14), 2618-2627.
Gasser, O., Schmid, T. A., Zenhaeusern, G., and Hess, C. (2006). "Cyclooxygenase
regulates cell surface expression of CXCR3/1-storing granules in human CD4+
T-cells." The Journal of Immunology, 177(12), 8806-8812.
Geiser, T., Dewald, B., Ehrengruber, M. U., Clark-Lewis, I., and Baggiolini, M. (1993).
"The interleukin-8-related chemotactic cytokines GRO-alpha, GRO-beta, and
GRO-gamma activate human neutrophil and basophil leukocytes." Journal of
Biological Chemistry, 268(21), 15419-24.
Grob, P. M., David, E., Warren, T. C., DeLeon, R. P., Farina, P. R., and Homon, C. A.
(1990). "Characterization of a receptor for human monocyte-derived neutrophil
chemotactic factor/interleukin-8." Journal of Biological Chemistry, 265(14), 83116.
Kandasamy, S., Green, B. B., Benjamin, A. L., and Kerr, D. E. (2011). "Between-cow
variation in dermal fibroblast response to lipopolysaccharide reflected in
resolution of inflammation during Escherichia coli mastitis." Journal of Dairy
Science, 94(12), 5963-5975.
Kettritz, R., Gaido, M. L., Haller, H., Luft, F. C., Jennette, C. J., and Falk, R. J. (1998).
"Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated
apoptosis of human neutrophils." Kidney International, 53(1), 84-91.
Lahouassa, H., Moussay, E., Rainard, P., and Riollet, C. (2007). "Differential cytokine
and chemokine responses of bovine mammary epithelial cells to Staphylococcus
aureus and Escherichia coli." Cytokine, 38(1), 12-21.
Lahouassa, H., Rainard, P., Caraty, A., and Riollet, C. (2008). "Identification and
characterization of a new interleukin-8 receptor in bovine species." Molecular
Immunology, 45(4), 1153-1164.

103

Lee, J., Horuk, R., Rice, G. C., Bennett, G. L., Camerato, T., and Wood, W. I. (1992).
"Characterization of two high affinity human interleukin-8 receptors." Journal of
Biological Chemistry, 267(23), 16283-7.
Li, F., and Gordon, J. R. (2001). "IL-8(3–73)K11R is a high affinity agonist of the
neutrophil CXCR1 and CXCR2." Biochemical and Biophysical Research
Communications, 286(3), 595-600.
Loetscher, P., Seitz, M., Clark-Lewis, I., Baggiolini, M., and Moser, B. (1994). "Both
interleukin-8 receptors independently mediate chemotaxis: Jurkat cells
transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GROα and NAP2." Federation of European Biochemical Societies Letters, 341(2–3), 187-192.
Madara, J. L., and Stafford, J. (1989). "Interferon-gamma directly affects barrier function
of cultured intestinal epithelial monolayers." Journal of Clinical Investigation,
83(2), 724.
Maheshwari, A., Christensen, R. D., and Calhoun, D. A. (2003). "ELR+ CXC
chemokines in human milk." Cytokine, 24(3), 91-102.
Miller, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., and Kreutzer,
D. L. (1998). "Expression of interleukin-8 receptors on tumor cells and vascular
endothelial cells in human breast cancer tissue." Anticancer Research, 18(1A),
77-81.
Moser, B., Barella, L., Mattei, S., Schumacher, C., Boulay, F., Colombo, M. P., and
Baggiolini, M. (1993). "Expression of transcripts for two interleukin 8 receptors in
human phagocytes, lymphocytes and melanoma cells." Biochemical Journal,
294, 285-292.
Nannuru, K. C., Sharma, B., Varney, M. L., and Singh, R. K. (2011). "Role of chemokine
receptor CXCR2 expression in mammary tumor growth, angiogenesis and
metastasis." Journal of Carcinogenesis, 10(40), 1477-3163.
Nickerson, S. C., and Heald, C. W. (1982). "Cells in local reaction to experimental
staphylococcus aureus infection in bovine mammary gland." Journal of Dairy
Science, 65(1), 105-116.
NMC. (2005). "The cost of mastitis: Dairy insight research 2005/2006: Final report."
National Mastitis Advisory Committee.
Paape, M., Mehrzad, J., Zhao, X., Detilleux, J., and Burvenich, C. (2002). "Defense of
the bovine mammary gland by polymorphonuclear neutrophil leukocytes."
Journal of Mammary Gland Biology and Neoplasia, 7(2), 109-21.

104

Park, G., Masi, T., Choi, C. K., Kim, H., Becker, J. M., and Sparer, T. E. (2010).
"Screening for novel constitutively active CXCR2 mutants and their cellular
effects", in P. M. Conn, (ed.), Methods in Enzymology. Academic Press, pp. 481497.
Petering, H., Götze, O., Kimmig, D., Smolarski, R., Kapp, A., and Elsner, J. (1999). "The
biologic role of interleukin-8: Functional analysis and expression of CXCR1 and
CXCR2 on human eosinophils." Blood, 93(2), 694-702.
Rainard, P., Riollet, C., Berthon, P., Cunha, P., Fromageau, A., Rossignol, C., and
Gilbert, F. B. (2008). "The chemokine CXCL3 is responsible for the constitutive
chemotactic activity of bovine milk for neutrophils." Molecular Immunology,
45(15), 4020-4027.
Richardson, R. M., Marjoram, R. J., Barak, L. S., and Snyderman, R. (2003). "Role of
the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration,
activation, and regulation." The Journal of Immunology, 170(6), 2904-11.
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S.,
and Lanzavecchia, A. (1998). "Rapid and coordinated switch in chemokine
receptor expression during dendritic cell maturation." European Journal of
Immunology, 28(9), 2760-2769.
Schmid, E., Schiller, D. L., Grund, C., Stadler, J., and Franke, W. W. (1983). "Tissue
type-specific expression of intermediate filament proteins in a cultured epithelial
cell line from bovine mammary gland." The Journal of Cell Biology, 96(1), 37-50.
Shafer-Weaver, K. A., Pighetti, G. M., and Sordillo, L. M. (1996). "Diminished mammary
gland lymphocyte functions parallel shifts in trafficking patterns during the
postpartum period." Experimental Biology and Medicine, 212(3), 271-279.
Shamaladevi, N., Lyn, D. A., Escudero, D. O., and Lokeshwar, B. L. (2009). "CXC
receptor-1 silencing inhibits androgen-independent prostate cancer." Cancer
Research, 69(21), 8265-8274.
Singer, A. J., and Clark, R. A. (1999). "Cutaneous wound healing." New England
Journal of Medicine, 341(10), 738-746.
Soehnlein, O., Kai-Larsen, Y., Frithiof, R., Sorensen, O. E., Kenne, E., ScharffetterKochanek, K., Eriksson, E. E., Herwald, H., Agerberth, B., and Lindbom, L.
(2008). "Neutrophil primary granule proteins HBP and HNP1–3 boost bacterial
phagocytosis by human and murine macrophages." The Journal of Clinical
Investigation, 118(10), 3491.

105

Sprenger, H., Lloyd, A. R., Lautens, L. L., Bonner, T. I., and Kelvin, D. J. (1994).
"Structure, genomic organization, and expression of the human interleukin-8
receptor B gene." Journal of Biological Chemistry, 269(15), 11065-72.
Strieter, R. M., Phan, S. H., Showell, H. J., Remick, D. G., Lynch, J. P., Genord, M.,
Raiford, C., Eskandari, M., Marks, R. M., and Kunkel, S. L. (1989). "Monokineinduced neutrophil chemotactic factor gene expression in human fibroblasts."
Journal of Biological Chemistry, 264(18), 10621-10626.
Sun, T.-T., Shih, C., and Green, H. (1979). "Keratin cytoskeletons in epithelial cells of
internal organs." Proceedings of the National Academy of Sciences, 76(6), 28132817.
Takata, H., Tomiyama, H., Fujiwara, M., Kobayashi, N., and Takiguchi, M. (2004).
"Expression of chemokine receptor CXCR1 on human effector CD8+ T-cells."
The Journal of Immunology, 173(4), 2231-2235.
Takeuchi, O., Hoshino, K., and Akira, S. (2000). "TLR2-deficient and MyD88-deficient
mice are highly susceptible to Staphylococcus aureus infection." The Journal of
Immunology, 165(10), 5392-6.
Walz, A., Burgener, R., Car, B., Baggiolini, M., Kunkel, S. L., and Strieter, R. M. (1991).
"Structure and neutrophil-activating properties of a novel inflammatory peptide
(ENA-78) with homology to interleukin-8." The Journal of Experimental Medicine,
174(6), 1355-1362.
Walz, A., Dewald, B., von Tscharner, V., and Baggiolini, M. (1989). "Effects of the
neutrophil-activating peptide NAP-2, platelet basic protein, connective tissueactivating peptide III and platelet factor 4 on human neutrophils." The Journal of
Experimental Medicine, 170(5), 1745-1750.
Watanabe, A., Yagi, Y., Shiono, H., Yokomizo, Y., and Inumaru, S. (2008). "Effects of
intramammary infusions of interleukin-8 on milk protein composition and
induction of acute-phase protein in cows during mammary involution." Canadian
Journal of Veterinary Research, 72(3), 291-6.
Wislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., Cody, D. D., Langley, R. R., Tang,
H., Burdick, M. D., Sato, M., Minna, J. D., Mao, L., Wistuba, I., Strieter, R. M.,
and Kurie, J. M. (2006). "High expression of ligands for chemokine receptor
CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras." Cancer
Research, 66(8), 4198-4207.
Zhao, X., and Lacasse, P. (2008). "Mammary tissue damage during bovine mastitis:
Causes and control." Journal of Animal Science, 86(13 suppl), 57-65.

106

Chapter IV: Genetic variation in CXCR1 haplotypes linked to clearance of
Streptococcus uberis infection in an experimental challenge model.
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Genetic variation in CXCR1 haplotypes linked to clearance of Streptococcus
uberis infection in an experimental challenge model.
L. Siebert, S. Headrick, M. Lewis, B. Gillespie, C. Young, L. Wojakiewicz, O. KerroDego, R. Almedia, S.P. Oliver, G.M. Pighetti
Abstract
Mastitis, an inflammation of the mammary gland, costs the dairy industry billions
in lost profits annually. The prevalence and loss associated with mastitis has made new
genetic selection methods a goal of research. Previous research has identified amino
acid changes at positions 122, 207, 245, 327, and 332 in the IL-8 receptor CXCR1 that
result in three dominant amino acid haplotypes: VWHKH, VWHRR, and AWQRR. We
hypothesize different haplotypes will influence a cow’s resistance or susceptibility to
developing mastitis. To test this, Holstein dairy cows (n=40) were intramammarily
challenged with S. uberis within three days post calving. All cows developed mastitis
based on isolation of S. uberis from the challenged quarter at least twice. All cows
(100%) with the VWHRR x VWHRR (n=5) and AWQRR x VWHRR (n=6) haplotype
combinations required antibiotic treatment to clear infection and were significantly
different from cows with a VWHRR x VWHKH (n=6) haplotype where only 33.33%
required antibiotic treatment (p=0.0153). Cows with a VWHRR homozygous haplotype
displayed significantly higher milk (1.05 ± 0.21) and mammary (1.23 ± 0.17) scores and
AWQRR x VWHRR cows had significantly lower milk (0.17 ± 0.18) and mammary (0.41
± 0.14) scores then cows of all other haplotype combinations (p=0.0263 and p=0.0161
respectively). Homozygotes for the VWHRR haplotype also displayed significantly
higher S. uberis bacteria counts (981.99 ± 1947.05) then cows of any other haplotype
combination (p=0.0348). Haplotype combination did not influence somatic cell counts
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(p=0.1399) and milk yield (p=0.6126). This evidence suggests VWHRR x VWHRR and
AWQRR x VWHRR cows are highly susceptible but VWHKH x VWHRR cows are less
susceptible to S. uberis based mastitis. Furthermore, the genetic haplotype of the
CXCR1 gene may have the ability to significantly influence the degree of inflammation
observed and bacterial clearance without aid of antibiotic treatments, supporting that
CXCR1 is critical for disease resistance.
Introduction
Mastitis is an ongoing issue in the dairy industry that costs producers billions in
lost profits annually in the forms of lost milk, antibiotic therapies, and extra labor costs
(NMC 2005). Improving overall herd quality through the use of genetic selection is a
predominant goal in the dairy industry. In keeping with this goal, efforts have been
made to identify single nucleotide polymorphisms (SNPs) within immune genes related
to phenotypic immune functions to help in genetic selection. One such study by Grosse
et al. (1999) surveyed a large array of bovine cytokines and cytokine receptors, among
them the gene for CXCR1. CXCR1 is the receptor for the immune mediator interleukin8 (IL-8). This receptor-ligand complex is responsible for several key immune responses
including neutrophil migration, increased host cell survival, and the modification of
chemokine/cytokine profiles (Grob et al. 1990; Kettritz et al. 1998; Soehnlein et al.
2008).
Four SNPs were identified in the bovine CXCR1 gene, three were synonymous
and the fourth caused a glutamine to histidine point mutation at position 245 in the
amino acid sequence of CXCR1 (Grosse et al. 1999). This SNP was published as
109

originating in CXCR2, but subsequent studies have revealed an improper annotation
indicating the SNP is actually in the bovine CXCR1 gene (Lahouassa et al. 2008;
Pighetti and Rambeaud 2006). Further examination of the CXCR1 gene revealed the
presence of the same four SNPs (+612, +777, +858, and +861) in several beef and
dairy breeds and a fifth SNP (+684) in Holstein and Jersey dairy breeds was identified
(Heaton et al. 2001; Youngerman et al. 2004b).
More extensive studies evaluated the association of specific SNPs and
haplotypes with mastitis. Youngerman et al. (2004b) identified SNPs at +612, +684,
+777, +858, and +861 in the CXCR1 gene. Four of the SNPs were synonymous, but
the +777 was linked to increased instance of subclinical and clinical mastitis
(Youngerman et al. 2004a). Leyva-Baca et al. (2008) recognized four SNPs associated
with the CXCR1 gene: -1830, -1768, +344, and +777. The +777 SNP corresponded to
the previously identified amino acid change at position 245, but showed no correlation
with increased somatic cell score (SCS), whereas the -1768 did, but only for the first
and second lactations (Leyva-Baca et al. 2008). A more in depth study of the +777
SNP revealed associations with calcium signaling upon IL-8 binding (Rambeaud and
Pighetti 2007), decreased neutrophil migration (Rambeaud and Pighetti 2005),
decreased reactive oxygen species (ROS) generation from neutrophils to aid in
bactericidal activities (Rambeaud et al. 2006), and increased neutrophil survival
(Rambeaud et al. 2006).
A compilation of SNPs in the CXCR1 gene also resulted in a change in the
naming convention of the SNPs to correlate with Human Genome Variation Society
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Guidelines (Pighetti et al. 2012). A total of 11 polymorphisms were identified within the
coding region of the bovine CXCR1 gene. Six SNPs were synonymous, four induced
amino acid changes (+365, +735 (formerly +777), +980, and +995), and one (+621)
induced an early stop codon (Pighetti et al. 2012). From the SNPs, amino acid
haplotypes based on the positions were identified and three (VWHKH, VWHRR,
AWQRR) were representative of more than 99% of the sample population (Table 12).
The increase in specificity gained by combining individual SNPs could provide a more
comprehensive and accurate means of genetic selection (Pighetti et al. 2012).
The majority of previous studies on CXCR1 SNPs have relied on field studies
(Grosse et al. 1999; Heaton et al. 2001; Leyva-Baca et al. 2008; Pighetti et al. 2012;
Youngerman et al. 2004a; Youngerman et al. 2004b). Field studies demonstrate that
the CXCR1 SNPs can be linked to natural incidence of clinical mastitis and bacterial
intramammary infection. However, studies have yet to determine if direct bacterial
challenge can also be tied to CXCR1 SNPs. Based on the existing knowledge of each
of the individual SNPs within the bovine CXCR1 gene, we suspect differences in a
cow’s resistance and susceptibility to mastitis. The goal of this study is evaluate the
relationship between CXCR1 haplotype and a cow’s susceptibility to and clearance of
infection following direct experimental challenge with Streptococcus uberis.
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Table 12: Relationships between CXCR1 tagSNP haplotype and amino acid haplotype
(Pighetti et al. 2012).

tagSNPi Haplotype
+621+735+816+980
GCCA
AGCG
GCAG
GGCG

Nucleotide
Haplotype
365-621-735-980-995
TGCAA
CAGGG
TGCGG
CGGGG

Amino Acid
Haplotype
122-206-245-327-332
VWHKH
AX
VWHRR
AWQRR

i

A tagSNP represents a group of SNPs in high linkage disequilibrium or non-random
allele association, increasing the probability that SNPs will be inherited together
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Materials and Methods
Animal Selection
This study was conducted using cows that were enrolled in a trial to test the
effectiveness of a novel vaccine candidate against S. uberis, i.e.: Streptococcus uberis
adhesion molecule (SUAM) (USDA-NIFA #2011-67015-30168). The forty Holstein dairy
cows used were clinically healthy, pregnant, and at the end of their first or second
lactation. Upon arrival at the ETREC Little River Dairy, the cows were allowed to
acclimate to the facility two weeks prior to the initiation of research protocols. Cows
were divided into sets of ten based on expected calving date for ease of sampling and
randomly assigned to the test vaccination (SUAM) or control vaccination (PBS) groups.
Cows were housed separately from the core herd and cared for in accordance with
ETREC Little River Dairy standard protocols. All animal based work was done in
accordance with Institutional Care and Use Committee (IACUC) guidelines.
Vaccination
The test vaccine contained 200µg recombinant SUAM that was isolated and
purified by Dr. Stephen Oliver’s lab. The control vaccine contained PBS instead of
SUAM. Both test and control vaccines contained the same adjuvant, Montanide
ISA70VG with an adjuvant/antigen ratio of 70/30. Each cow received a series of three
vaccinations where the total volume of each dose was 2mL and given on alternate sides
of the neck. Vaccinations were administered in four week intervals at -84 days, -56
days, and -28 days prior to expected calving date. Following each administration,
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injection sites and temperatures were closely monitored for adverse reactions to the
vaccination.
Challenge
Approximately 1 week prior to calving, secretion samples were collected from
each quarter to screen for bacterial presence and aid in selecting the challenge quarter.
A frozen stock of Streptococcus uberis (UT888) was thawed and allowed to grow at
37°C in Todd Hewitt Broth until turbid. The culture then was serially diluted in PBS to
approximately 2000 CFU/mL for infusion into the selected challenge quarter. Each cow
was challenged within three days after calving with a total volume of 5mL of the dilute S.
uberis culture just after milking was complete. The challenge inoculum was diluted
serially and plated to determine the actual concentration of S. uberis delivered.
Sampling and Basis for Antibiotic Treatment
Time points for collection included: immediately before challenge (0 days) and
then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 14, 21, and 28 days post
challenge. Milk samples were used to identify the concentration of S. uberis present.
Milk and mammary quarter scores were evaluated on a 0-3 scale. Milk scores were
defined as follows: 0=normal, 1=small flakes/clots, 2=large clots, 3=stringy, off color,
watery, or bloody. Mammary scores were defined as follows: 0=normal, 1=slight
swelling, 2=moderate swelling, 3=edema. Scores were evaluated by Charlie Young or
Mark Lewis of the ETREC Little River Staff. Three consecutive sets of severe scores (a
2 in both milk and mammary scores, or a 3 in either) was considered grounds for
antibiotic treatment. Alternatively, if cows had not cleared S. uberis ≥ 14 days post
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challenge of their own accord, antibiotic treatment was administered without clinical
signs being present. Somatic cell counts were collected and determined by the
Tennessee Dairy Herd Information Association (DHIA) lab (Knoxville, TN). Bacteria
counts were determined by growth on blood agar plates and were evaluated by Barbara
Gillespie or Susan Headrick of the Tennessee Quality Milk Lab (Knoxville, TN) using
guidelines established in the NMC lab handbook (NMC 1999). Milk yields were
recorded daily by the milking system at the ETREC Little River Dairy.
Haplotyping
A blood sample from each cow was collected via jugular vein prior to the
administration of the third vaccination and DNA was isolated from whole blood using
UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA). Part of the CXCR1
gene was amplified as follows: 1-2 ng of bovine genomic DNA was used as template in
a 25 µl reaction containing specific primers and Eppendorf HotMaster Mix (Eppendorf
North America; Westbury, NY) according to manufacturer's guidelines. The conditions
for amplification were as follows: an initial hot-start denaturation occurred at 94oC for
2min, followed by 50 cycles of 94oC denaturation for 15 sec, 62oC annealing for 20sec,
and 72oC extension for 60 sec. After the last cycle, a 10 minute final extension step at
72oC was added before reactions were chilled to 4oC. Amplified products were purified
to remove primer and excess nucleotides. Haplotypes were generated using PHASE
(Stephens and Scheet 2005; Stephens et al. 2001). The resulting DNA was sequenced
using bovine CXCR1 specific primers (Youngerman et al. 2004a) and the CXCR1
haplotype was determined based on nucleotide expression at tagSNP positions +621,
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+735, +816, and +980 in the CXCR1 gene. The haplotypes of two cows could not be
resolved and were not included in analyses.
Statistical Analysis
The experiment was a randomized block design with repeated measures tied to
time. Significance was declared at p<0.05, and a trend was declared at p=0.05 to
p=0.1. A mixed model using glimmix tested the fixed effects of CXCR1 haplotype,
vaccination, time and the two way interactions of each, with time declared as repeated
measures. The random effect of cow nested within CXCR1 haplotype also was
included. Many covariates were tested for each response variable and include:
lactation number, challenge group, rectal temperature, days between calving and
challenge (challenge interval), necessity of antibiotic treatment and time between
vaccinations and challenge. Of these covariates, necessity of antibiotic treatment was
used for milk scores, mammary scores, somatic cell counts, S. uberis counts, and milk
yield. Analyses were performed in SAS (Cary, NC) using a mixed model analysis of
variation with Fisher’s LSD for means separation of numeric relationships and chisquare for frequencies. Three cows, 218 (AWQRR x AWQRR), 221 (AWQRR x
VWHRR), and 230 (AWQRR x AWQRR) were excluded from all response variable
analyses because they were sacrificed early in the trial for experimental reasons and it
is unknown if they would require antibiotic treatment. A significant influence of vaccine
was not observed for any response variables and will not be discussed.
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Results
There were 40 Holstein dairy cows in this study. The dominant haplotype
combination was homozygous for AWQRR and represented 28.95% (11/38) of the
cows. The second most frequent haplotype combination was AWQRR x VHWKH
representing 23.68% (9/38) of the cows. The remaining three haplotype combinations
represented smaller percentages of the population and are outlined in Table 13.
The relationship between necessity of antibiotics and time to administration of
antibiotics are summarized in Figure 10. The majority of cows (74.29%, 26/35) in the
study required treatment with antibiotics. All cows with VWHRR x VWHRR or AWQRR
x VWHRR haplotypes required antibiotic treatment and tended to be different from cows
with VWHKH x VWHRR haplotype where only 33.33% needed antibiotic treatment
(p=0.0838). The remaining two haplotypes, AWQRR x VWHKH and AWQRR x
AWQRR, had results between both extremes with 75% and 70% of cows needing
antibiotic treatment respectively. Cows with the AWQRR x VWHRR haplotype took
significantly longer to require treatment, with the administration of the first treatment
13.59 ± 1.73 days post challenge (p=0.0003). The remaining four haplotypes required
treatment at or before 4.02 ± 1.47 days post challenge.
Milk scores or the degree if inflammation, observed at each time point
demonstrated AWQRR x VWHRR cows had significantly lower scores then cows of
other haplotypes, except for VWHKH x VWHRR cows, which were more comparable.
Cows with the AWQRR x VWHRR haplotype combination never reached average milk
scores ≥1 for an individual time point and averaged 0.1735 ± 0.1835 overall (p=0.0263).
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In contrast, VWHRR homozygous cows reached high milk scores (≥1) within three days
post challenge and remained high until nine days post challenge and had an average
milk score of 1.048 ± 0.2094. The remaining three haplotype combinations shared
similarities with both extremes (Figure 11).
Mammary scores for VWHRR homozygous cows were significantly greater than
all other genetic backgrounds. Average mammary scores ≥1 were reached within two
days post challenge, remained elevated until 11 days post challenge, averaging 1.23 ±
0.1668. The AWQRR x VWHRR cows which had the lowest milk scores compared to
most other genetic backgrounds also had significantly lower mammary scores than the
VWHRR homozygous and AWQRR homozygous haplotype combinations averaging
0.4123 ± 0.1442 (p=0.0161) (Figure 12).
Somatic cell counts and S. uberis counts also were observed at each time point.
Haplotype had no effect on somatic cell counts with all ranging between 106 and 107
c/mL regardless of time point (p=0.1399) (Figure 13). S. uberis counts were influenced
by haplotype. Cows with the VWHRR x VWHRR haplotype had significantly higher
numbers of S. uberis isolated from their infected quarter in comparison to cows from the
other four haplotypes (p=0.0348). VWHRR x VWHRR cows averaged 981.996 ±
1947.05 CFU/mL whereas the other four haplotypes were 4.108 ± 4.42 CFU/mL or
lower (Table 14). Milk yields were recorded on each day of sampling and were not
influenced by haplotype (p=0.6126). All haplotypes had average daily weights ranging
between 23.21 and 27.34 ± 2.62 kilograms per cow and each haplotype group
demonstrated a steady increase over time (Figure 15).
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Table 13: Frequency of haplotypes observed in sample population of Holstein dairy
cows.

Haplotype
VWHRR x VWHRR
VWHKH x VWHRR
AWQRR x VWHRR
AWQRR x VWHKH
AWQRR x AWQRR
Total

Count
5
7
6
9
11
38

Percentage
13.16
18.42
15.79
23.68
28.95
100.00
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Antibiotic Treatment NOT
Required (%)

Time Post Challenge (Days)

Figure 10: Percentage of and time to antibiotic treatment for each haplotype following S.
uberis intramammary challenge. Letters (a, b) represent significant differences between
haplotypes (p=0.0838).
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Figure 11: The effect of CXCR1 haplotype combination on milk scores following S.
uberis intramammary challenge. A covariate of necessity of antibiotic treatment was
included (p=<0.0001). Letters (a, b) represent significant differences between
haplotypes (p=0.0263).
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Figure 12: The effect of haplotype on mammary scores following S. uberis
intramammary challenge. A covariate of necessity of antibiotic treatment was included
(p=0.0002). Letters (a, b, c) represent significant differences between haplotypes
(p=0.0161).
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Figure 13: The effect of haplotype on somatic cell counts following S. uberis
intramammary challenge. A covariate of necessity of antibiotic treatment was included
(p=<0.0001). No significant differences were observed in somatic cell counts across
haplotypes (p=0.1399).
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Table 14: The effect of haplotype on S. uberis counts following S. uberis intramammary
challenge.

Day

VWHRR
x
VWHRRa

0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
9
11
14
16
18
21
23
25
28
SEM ii

0
619.72
9714.68
18257.3
70083.38
337238.32
400230.59
201136.67
791880.14
302270.55
237818.62
613894.22
58667279
1.456E+09
2.16
0.01
0
0.02
1.69
0
1302.37
47.84
107505.49
47.22
413183348.8

Haplotypei
VWHRR
VWHRR
x
x
b
VWHKH
AWQRRb
0.01
0
12424.73
20.41
162951.56
2296.61
40792.42
623.59
298.56
48.6
169.47
0.71
6314.32
38.74
269.71
430.84
71.99
777.07
110.63
318.79
33.05
2167.32
32.95
234.22
10.43
94.14
25.55
5.79
0.18
0.65
0
0
0
0
0.02
0.11
0.03
0
0.08
0
0.03
0.01
0.02
0
0
0
0
0
29692.88
993.72

i

VWHKH
AWQRR
x
x
b
AWQRR
AWQRRb
0
0
25.22
18.04
72.32
67.04
590.14
364.43
295.49
7969.93
1101.13
53153.56
602.46 127893.25
892.44
188686.6
1315.69
66615.61
609.51
54650.87
7754.51
27477.93
408.95
7742.82
79.4
732.87
8.55
3.54
0.22
0
0.09
0
0
0
0
0
0
0
0
0.01
0
0.01
0
0
0
1.64
0
0
2004.05
57759.93

Haplotype combinations with different letters differ (p=0.0348) with a covariate of
necessity of antibiotic treatment (p=0.0002).
ii

SEM: standard error of the mean.
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Figure 14: The effect of haplotype on milk yield following S. uberis intramammary
challenge. A covariate of necessity of antibiotic treatment was included (p=0.2211). No
significant differences were observed in somatic cell counts across haplotypes
(p=0.6126).
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Discussion
The objective of this study was to determine the association between CXCR1
haplotype and resistance or susceptibility to S. uberis based mastitis. The common
observed infection rate for S. uberis following experimental challenge is about 70%
(Rambeaud et al. 2003). However, we observed a 100% infection rate based on S.
uberis presence. This difference in number of cows developing infection is most likely
attributed to differences in days in milk (DIM). Cows in our study were three or less DIM
and cows in the Rambeaud et al. (2003) study were between 11 and 38 DIM. Cows are
more susceptible to developing mastitis within the periparturient period due mainly to
decreased neutrophil function (Cai et al. 1994; Oliver and Sordillo 1988; Sordillo and
Streicher 2002). The 100% infection rate caused us to reevaluate our definition of
resistance in this study. As a result, we focused on the need for antibiotic treatment,
which resulted in three groups. The first group contained cows with haplotype
combinations VWHRR x VWHRR and AWQRR x VWHRR where 100% of cows
required antibiotic treatment. Cows with the VWHRR x VWHRR haplotype combination
were highly inflammatory. They developed average milk and mammary scores ≥1
within 2.5 days post challenge, reached S. uberis counts statistically higher than other
haplotype combinations, and all required antibiotic treatment within seven days post
challenge. Contrastingly, the AWQRR x VWHRR haplotype combination still required
100% antibiotic treatment but were much less inflammatory in response. AWQRR x
VWHRR cows did not reach milk or mammary scores ≥1 and had S. uberis counts
statistically similar to all haplotype combinations besides VWHRR x VWHRR. Half of
the AWQRR x VWHRR cows received treatment within seven days post challenge as a
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consequence of inflammatory milk and mammary scores. The other half did not receive
treatment until 18-26 days post challenge and were received antibiotic treatment
because cows were still shedding S. uberis. The second group contained AWQRR x
VWHKH and AQWRR x AWQRR cows with only 70 or 75% requiring treatment. The
last group contained cows with the VWHKH x VWHRR haplotype combination where
only 33.33% required antibiotic treatment. Within the groups requiring less than 100%
antibiotic treatment, cows developed elevated milk and mammary scores ≥1 within two
days post challenge and had statistically similar S. uberis counts to all haplotypes
except VWHRR homozygous cows. Cows that required antibiotic treatment in the
groups with less than 100% antibiotic treatment were all treated by 7 days post
challenge for severe clinical signs.
The variation observed amongst the different groups can potentially be explained
by the theoretical influence of amino acid changing SNPs in the CXCR1 gene. VWHRR
homozygous cows required 100% antibiotic treatment within seven days post challenge
because of severe clinical signs. These cows are homozygous for the +365 SNP that
corresponds to amino acid position 122 in the CXCR1 amino acid sequence. The valine
at position 122 has been associated with ligand binding and strength due to its location
in the first transmembrane domain, which is essential for any downstream effects to be
carried out (Leong et al. 1994; Monteclaro and Charo 1996). These cows are also
homozygous for the tryptophan amino acid at position 206 in the CXCR1 amino acid
sequence. This is a conserved amino acid across all of the observed haplotypes
because the alternative ghis a stop codon that results in no receptor expression or a
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truncated receptor which both result in an inability for CXCR1 to respond to ligand.
Cows homozygous for the VWHRR haplotype are homozygous for the C allele at the
+735 SNP and histidine at position 245 in the amino acid sequence. The 245 position
has been witnessed to associate with neutrophil migration, survival, and ROS
generation as well as intracellular calcium signaling. Expression of histidine at position
245 instead of the conserved glutamine residue has been tied to decreases in these
functions in homozygous cows (Rambeaud et al. 2006; Rambeaud and Pighetti 2007;
Rambeaud and Pighetti 2005). This suggests that VWHRR homozygous cows may
have decreased ability to induce internal calcium signaling and subsequent neutrophil
migration, survival, and ROS generation. Furthermore, the +980 and +995 SNPs
corresponding to arginine at positions 327 and 332 respectively in the amino acid
sequence have been linked to the ability to bind internal mediators and initialize internal
signaling, internalize the receptor and induce migration, although more importance is
given to the 327 position (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010).
Expression of arginine at the 327 position in CXCR2 alters the KILAIHGLI motif and
reduces the ability of the C-terminus to bind internal mediators and cause downstream
effects such as receptor internalization and subsequent migration (Fan et al. 2002; Fan
et al. 2000; Raman et al. 2010; Yang et al. 1999). The potential decrease in internal
signaling and receptor internalization that could be associated with VWHRR
homozygous cows could allow S. uberis to establish infection easier and proliferate
more within the gland. The greater S. uberis load may lead to the highly inflammatory
responses seen and the need for all to receive antibiotic treatment within seven days
post challenge.
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VWHRR homozygous and VWHKH x VWHRR cows displayed dramatic
differences in their need for antibiotic treatment. Only 33.33% of VWHKH x VWHRR
cows required treatment as opposed to 100% of VWHRR homozygous cows. Cows
with the VWHKH x VWHRR haplotype combination share several similarities with
VWHRR homozygous cows having one identical allele and the other allele differing in
only the two terminal amino acids. This suggests that they too may have decreased
ability to induce neutrophil migration, survival, and ROS generation as well as internal
calcium signaling (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and
Pighetti 2005). The terminal lysine and histidine residues are involved in the KILAIHGLI
motif of the C-terminus of the CXCR1 receptor. The KILAIHGLI motif is linked to
adaptin-2/LASP-1 and HSP-70 interacting protein (Hip) binding to the C-terminus of
CXCR1 (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010). Mutations within this
motif have demonstrated decreased adaptin-2 or Hip binding resulting in decreased
receptor internalization and subsequent migration (Raman et al. 2010). Cows with the
VWHKH x VWHRR haplotype combination possess one mutated and one wild type
haplotype for this motif suggesting they may have intermediate ability to bind adaptin-2
or Hip and cause subsequent receptor internalization and migration. However, because
VWHKH x VWHRR cows displayed a decreased need for antibiotic treatment compared
to VWHRR homozygous cows, this suggests that the C-terminal amino acid positions
327 and 332 play a greater role in the ability of CXCR1 to properly respond to ligand
stimulation in comparison to the 245 amino acid. Furthermore, these terminal amino
acids are most likely responsible in providing some VWHKH x VWHRR cows with the
ability to clear S. uberis mastitis without the aid of antibiotic treatment.
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Cows with the AWQRR x VWHRR haplotype combination also required 100%
antibiotic treatment, but were much less inflammatory then VWHRR homozygous cows.
Their lower inflammatory response suggests the AWQRR haplotype may impair the
ability to kill S. uberis efficiently. These cows are heterozygous for the +365 SNP that
corresponds to amino acid position 122. The 122 position is conserved across five
species and has been linked to ligand binding and strength due to its location in the first
transmembrane domain (Leong et al. 1994; Monteclaro and Charo 1996; Pighetti et al.
2012). An amino acid change from valine to alanine could cause a conformational
change or alter the hydrophobicity of the transmembrane domain and potentially result
in a reduced ability to bind ligand or reduced binding strength (Leong et al. 1994;
Monteclaro and Charo 1996). These cows are also heterozygous for the 245 amino
acid position. In previous studies, cows that are heterozygous at the 245 position
display have displayed neutrophil migration, survival, ROS generation, and internal
calcium signaling ability similar to both homozygous extremes (Rambeaud et al. 2006;
Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005). Overall, this suggests the
AWQRR haplotype could be impaired in ligand binding as well as adaptin-2 or Hip
binding and subsequent receptor internalization and migration. The proposed abilities
of each haplotype within the AWQRR x VWHRR haplotype combination suggest they
may have decreased ability to bind ligand and carry out subsequent downstream effects
of ligand binding. This could explain the low inflammatory response coupled with the
inability to completely clear S. uberis from the gland and require antibiotic treatment due
to S. uberis’ continued presence witnessed with these cows.
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The remaining two haplotype combinations, AWQRR x VWHKH and AWQRR x
AWQRR, required intermediate levels (70-75%) of antibiotic treatment. These
haplotype combinations share similarities in proposed receptor ability with the other two
antibiotic treatment groups previously discussed. The AWQRR x VWHKH cows are
heterozygous for amino acid positions 122, 245, 327, and 332. This indicates they will
most likely display intermediate abilities in ligand binding tied to position 122;
intermediate neutrophil migration, survival, killing ability and internal calcium signaling
tied to the 245 position; and intermediate abilities in initiating internal signaling based on
the altered KILAIHGLI motif tied to positions 327 and 332 as previously discussed. The
AWQRR homozygous cows will most likely display decreased ability to bind ligand due
to being homozygous for alanine at position 122 and decreased ability to bind adaptin-2
or Hip to initialize internalization and subsequent migration because of the homozygous
arginines at positions 327 and 332 altering binding ability of the KILAIHGLI motif. The
proposed abilities of the AWQRR x VWHKH and AWQRR x AWQRR cows can be
linked to the responses witnessed for these cows within our study where the majority
(70-75%) of cows required antibiotic treatment. Those cows that required antibiotic
treatment displayed inflammatory signs and were treated within 7 days post challenge
indicating a possible inability to properly control the infection through immune
responses.
Increased somatic cell counts are often associated with a state of infection within
the mammary gland because immune cells are heavily recruited to the site to fight
infection. Somatic cells are present within milk when the mammary gland is healthy at
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lower concentrations, generally ≤ 200,000 c/mL, but increase dramatically upon
incidence of infection to about 700,000 c/mL or higher, but can vary depending on
pathogen (Bannerman et al. 2004; Rambeaud et al. 2003). The findings of this study
followed a similar pattern with somatic cell counts originating at approximately 150,000
c/mL and resulting in over 8,000,000 c/mL. Because of the association of the 245
amino acid position with neutrophil migration (Rambeaud and Pighetti 2005), initial
thoughts were that somatic cell counts would differ based on amino acid expression at
position 245. However, several studies have provided conflicting results. Youngerman
et al. (2004a) demonstrated Holsteins heterozygous at the 245 position displayed higher
somatic cell scores (SCS) than Holsteins homozygous for histidine at the 245 position
and Jerseys showed no such association. Subsequent studies did not confirm an
association between the 245 position and SCS (Beecher et al. 2010; Goertz et al. 2009;
Leyva-Baca et al. 2008). Our study, looking at the effect of haplotype instead of a
single SNP, also did not display differences in somatic cell counts. The IL-8/CXCR1
ligand-receptor complex is not the only complex responsible for neutrophil migration.
Other ELR+ chemokines including, GRO-α, β, γ, ENA-78, IL-8, GCP-2 and NAP-2 are
ligands for the functionally similar CXCR2 receptor (Ahuja and Murphy 1996; Lee et al.
1992). Binding of these ELR+ chemokines to the CXCR2 receptor has been
demonstrated to induce neutrophil migration (Geiser et al. 1993; Lahouassa et al. 2008;
Walz et al. 1991; Walz et al. 1989). Thus it is possible that differences in somatic cell
counts are not witnessed based on CXCR1 haplotype because the other ligand-receptor
complexes aid in recruiting neutrophils. Furthermore, during the infection state, the bulk
of somatic cells in milk are neutrophils, but other cell populations are present and
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include: macrophages, lymphocytes ( CD4+ and CD8+ T-cells) and epithelial cells
(Boutinaud and Jammes 2002). Thus, an increase in another subpopulation of somatic
cells may contribute to the lack of variation observed.
This research indicates there are differences in responses to S. uberis
experimental challenge based upon CXCR1 haplotype. All cows developed mastitis
indicating resistance could not be attributed to CXCR1 haplotype in an experimental
challenge model given under immune compromised conditions. However, differences in
susceptibility based on CXCR1 haplotype were observed relative to the need for
antibiotic treatment as well as the degree of bacterial growth and inflammation. Of
these, cows with a VWHKH x VWHRR haplotype combination required only 33.33%
antibiotic treatment and may represent a desirable genetic marker due to their proposed
ability to clear infection efficiently without antibiotic treatment during a highly susceptible
period.
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Chapter V: Conclusion
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The first objective of this study was to evaluate types of cells expressing CXCR1
and CXCR2 in the bovine mammary gland. We identified expression of CXCR1 on
alveolar epithelial cells, fibroblasts and leukocytes. Expression of CXCR1 has been
witnessed on mammary stem cells, cancerous mammary epithelial cells, and epithelial
cells from other species and/or tissues, thus CXCR1 expression on alveolar epithelial
cells in the mammary gland was not a novel discovery (Ben-Baruch 2003; Miller et al.
1998; Wislez et al. 2006). The expression of CXCR1 on both fibroblasts and
leukocytes were not unexpected findings as CXCR1 has been observed on cultured
human fibroblasts (Moser et al. 1993), neutrophils (Grob et al. 1990), dendritic cells
(Sallusto et al. 1998), natural killer cells (Berahovich et al. 2006), CD4+ T-cells (Gasser
et al. 2006), CD8+ T-cells (Takata et al. 2004), and eosinophils (Petering et al. 1999).
Expression of CXCR2 on alveolar epithelia cells and leukocytes also was demonstrated.
Neither expression of CXCR2 on alveolar epithelial cells nor leukocytes were
unexpected due to the prior discovery of CXCR2 expression on cultured epithelial cells
(Park et al. 2010), neutrophils (Sprenger et al. 1994), and eosinophils (Petering et al.
1999).
The results of the first objective indicate that not only leukocytes, but also
alveolar epithelial cells and fibroblasts are capable of responding to released ELR +
chemokines indicative of an inflammatory state. For neutrophils, binding of ELR+
chemokine to CXCR1 or CXCR2 induces migration, survival and modifies secreted
chemokine/cytokine profiles (Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Kettritz
et al. 1998; Soehnlein et al. 2008). Expression of CXCR1 and CXCR2 on alveolar
epithelial cells, fibroblasts, and other leukocytes theoretically provides the same benefits
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of increasing migration, increasing survival and modifying chemokine/cytokine profiles.
Future studies should evaluate the in vitro abilities of bovine mammary alveolar
epithelial cells, fibroblasts and leukocyte subsets for their abilities to migrate, survive
and modify chemokine/cytokine profiles upon addition of ELR+ chemokines.
Expression of CXCR1 or CXCR2 in human mammary tissue is typically linked to
cancer cells (Ben-Baruch 2003; Charafe-Jauffret et al. 2009). However, unlike the
bovine mammary gland, lactation in the human mammary gland is a temporary state,
thus native expression of CXCR1 and CXCR2 in the bovine mammary gland could be
attributed to the perpetual state of lactation. To test this, mammary tissue samples from
non-lactating heifers, dried off cows, and cows of varying stages of lactation should be
assessed for CXCR1 and CXCR2 native expression. Furthermore, expression of the
receptor does not demand a correlation to ligand secretion, indicating that the receptor
may be present and unbound and only responds when ligand is released. An
examination of what transcription factors and promoter sequences allow CXCR1 and
CXCR2 expression in the bovine mammary gland could better illuminate this
relationship.
The second objective of this study was to determine the association of CXCR1
haplotype on resistance and susceptibility to direct S. uberis challenge. We observed a
100% infection rate resulting in the reevaluation our definition of resistance in this study
that focused on the need for antibiotic treatment. This resulted in three groups:
VWHRR x VWHRR and AWQRR x VWHRR where 100% required antibiotic treatment,
AWQRR x VWHKH and AQWRR x AWQRR where 70 or 75% required antibiotic
treatment and VWHKH x VWHRR where 33.33% required antibiotic treatment.
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The results from the second objective indicate that the combination of individual
SNPs within a haplotype as well as the haplotype combination play an intricate role in
the phenotype observed. Cows homozygous for the VWHRR or AWQRR haplotype
shared the terminal two arginine residues and all required treatment. This indicates that
the C-terminus involving the KILAIHGLI motif is essential for combating infection
through internal binding of adaptin-2 or Hip and subsequent receptor internalization and
chemotaxis (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010). Although focused on
by several previous studies, the amino acid residue at position 245 does not appear to
have as great an influence on observed phenotype as the terminal 327 and 332
residues. Further evidence of this comes from the VWHKH x VWHRR cows displaying
the ability to clear the infection without the aid of antibiotics in the majority of cases.
However, VWHRR homozygous and AWQRR homozygous cows did differ greatly in the
phenotypic level of inflammation observed. VWHRR cows were highly inflammatory
and AWQRR homozygous cows displayed the least amount of overall inflammation of
all observed haplotype combinations in this study. This indicates that the 245 position
may be greatly linked to the intensity of the generated immune response most likely tied
to the neutrophil migration, survival, ROS generation and internal calcium signaling
observed with the glutamine residue at this position (Rambeaud et al. 2006; Rambeaud
and Pighetti 2007; Rambeaud and Pighetti 2005). These cows also differed at the 122
amino acid position. The 122 position has been previously associated with ligand
binding and strength and may also be associated with the differences observed
between the two homozygous haplotype groups likely tied to the ability to bind ligand
(Leong et al. 1994; Monteclaro and Charo 1996).
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To further support these conclusions, transfectants representative of each
haplotype group should be generated and evaluated in vitro for their ability to migrate,
survive, and modify chemokine/cytokine profiles upon stimulation with ELR +
chemokines. Furthermore, the infection state is associated with cellular damage.
Damaged cells are typically cleared by macrophages (Gordon 1998). If cows of a
certain haplotype group (VWHRR x VWHRR) are less capable of resisting mastitis, the
bacteria will be present within the gland in higher numbers and capable of causing more
cell damage. The end result will be more scar tissue and less active parenchyma to
produce milk. These cows would then be more likely to be culled from the herd at a
younger age then cows of other haplotype groups due to decreased milk yield. An
evaluation of how long cows of each haplotype group stay in the active milking herd
could divulge if a trend is present and if further studies are of interest.
Coupling together the knowledge from these two objectives could be the
beginning of understanding the important role that the CXCR1/IL-8 receptor-ligand
complex plays in mastitis. Based on our results, we know that several populations of
cells are natively expressing CXCR1 in the bovine mammary gland and that differences
are seen based on CXCR1 haplotype in response to experimental S. uberis challenge.
Therefore, the proposed abilities of each haplotype can be linked not only to immune
cells but also epithelial cells and some fibroblasts. Combining the previously proposed
in vitro studies to test the migration, survival, and chemokine/cytokine profiles of all cell
populations expressing CXCR1 and each CXCR1 haplotype combination should
provide invaluable information potentially leading to reduces mastitis.
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